// Medication data and related functions
const medicationData = [

    { 
        name: "INSPAGO 25mg Tab.", 
        active: "Agomelatine", 
        category: "Melatonin Receptor Agonist (Antidepressant)",
        available: false,
        package: "14 TAB",
        halfLife: "1-2 hours",
        sideEffects: ["Nausea", "dizziness", "insomnia", "headache", "anxiety", "liver enzyme increases"],
        interactions: ["Strong CYP1A2 inhibitors (e.g., Fluvoxamine)", "Alcohol"],
        monitor: ["Liver function", "mood changes", "sleep patterns"],
        importantInvestigations: ["Liver Function Tests (LFTs) - Baseline and periodic"]
    },
    { 
        name: "AGOVALD 25mg Tab.", 
        active: "Agomelatine", 
        category: "Melatonin Receptor Agonist (Antidepressant)",
        available: true,
        package: "21 TAB",
        halfLife: "1-2 hours",
        sideEffects: ["Nausea", "dizziness", "insomnia", "headache", "anxiety", "liver enzyme increases"],
        interactions: ["Strong CYP1A2 inhibitors (e.g., Fluvoxamine)", "Alcohol"],
        monitor: ["Liver function", "mood changes", "sleep patterns"],
        importantInvestigations: ["Liver Function Tests (LFTs) - Baseline and periodic"]
    },
    { 
        name: "VALDOXANE 25mg Tab.", 
        active: "Agomelatine", 
        category: "Melatonin Receptor Agonist (Antidepressant)",
        available: false,
        package: "14 TAB",
        halfLife: "1-2 hours",
        sideEffects: ["Nausea", "dizziness", "insomnia", "headache", "anxiety", "liver enzyme increases"],
        interactions: ["Strong CYP1A2 inhibitors (e.g., Fluvoxamine)", "Alcohol"],
        monitor: ["Liver function", "mood changes", "sleep patterns"],
        importantInvestigations: ["Liver Function Tests (LFTs) - Baseline and periodic"]
    },
    { 
        name: "ZOLAM 0.25mg Tab.", 
        active: "Alprazolam", 
        category: "Benzodiazepine (Anxiolytic)",
        available: true,
        package: "30 TAB",
        halfLife: "6-12 hours",
        sideEffects: ["Sedation", "dizziness", "fatigue", "ataxia", "memory impairment", "dependence"],
        interactions: ["Alcohol", "Opioids", "Other CNS depressants", "CYP3A4 inhibitors (e.g., Ketoconazole)"],
        monitor: ["Sedation", "dizziness", "cognitive impairment", "risk of dependence", "withdrawal symptoms"],
        importantInvestigations: ["None routine; caution in hepatic impairment"]
    },
    { 
        name: "ZOLAM 0.5mg Tab.", 
        active: "Alprazolam", 
        category: "Benzodiazepine (Anxiolytic)",
        available: true,
        package: "30 TAB",
        halfLife: "6-12 hours",
        sideEffects: ["Sedation", "dizziness", "fatigue", "ataxia", "memory impairment", "dependence"],
        interactions: ["Alcohol", "Opioids", "Other CNS depressants", "CYP3A4 inhibitors (e.g., Ketoconazole)"],
        monitor: ["Sedation", "dizziness", "cognitive impairment", "risk of dependence", "withdrawal symptoms"],
        importantInvestigations: ["None routine; caution in hepatic impairment"]
    },
    { 
        name: "XANAX 0.5mg Tab.", 
        active: "Alprazolam", 
        category: "Benzodiazepine (Anxiolytic)",
        available: false,
        package: "30 TAB",
        halfLife: "6-12 hours",
        sideEffects: ["Sedation", "dizziness", "fatigue", "ataxia", "memory impairment", "dependence"],
        interactions: ["Alcohol", "Opioids", "Other CNS depressants", "CYP3A4 inhibitors (e.g., Ketoconazole)"],
        monitor: ["Sedation", "dizziness", "cognitive impairment", "risk of dependence", "withdrawal symptoms"],
        importantInvestigations: ["None routine; caution in hepatic impairment"]
    },
    { 
        name: "XANAX 0.5mg Tab.", 
        active: "Alprazolam", 
        category: "Benzodiazepine (Anxiolytic)",
        available: false,
        package: "100 TAB",
        halfLife: "6-12 hours",
        sideEffects: ["Sedation", "dizziness", "fatigue", "ataxia", "memory impairment", "dependence"],
        interactions: ["Alcohol", "Opioids", "Other CNS depressants", "CYP3A4 inhibitors (e.g., Ketoconazole)"],
        monitor: ["Sedation", "dizziness", "cognitive impairment", "risk of dependence", "withdrawal symptoms"],
        importantInvestigations: ["None routine; caution in hepatic impairment"]
    },
    { 
        name: "PK-MERZ INFUSION", 
        active: "Amantadine", 
        category: "NMDA Receptor Antagonist (Antiviral, Anti-Parkinson's)",
        available: true,
        package: "1 BOTTLE",
        halfLife: "12-17 hours",
        sideEffects: ["Nausea", "dizziness", "insomnia", "livedo reticularis", "ankle edema", "anticholinergic effects"],
        interactions: ["Anticholinergic drugs", "CNS stimulants", "Memantine"],
        monitor: ["Neuropsychiatric effects (confusion, hallucinations)", "orthostatic hypotension", "livedo reticularis", "edema"],
        importantInvestigations: ["Renal function (dose adjustment needed)", "None routine for CNS use"]
    },
    { 
        name: "PK-MERZ 100mg Tab.", 
        active: "Amantadine", 
        category: "NMDA Receptor Antagonist (Antiviral, Anti-Parkinson's)",
        available: true,
        package: "30 TAB",
        halfLife: "12-17 hours",
        sideEffects: ["Nausea", "dizziness", "insomnia", "livedo reticularis", "ankle edema", "anticholinergic effects"],
        interactions: ["Anticholinergic drugs", "CNS stimulants", "Memantine"],
        monitor: ["Neuropsychiatric effects (confusion, hallucinations)", "orthostatic hypotension", "livedo reticularis", "edema"],
        importantInvestigations: ["Renal function (dose adjustment needed)", "None routine for CNS use"]
    },
    { 
        name: "AMIPRIDE 200mg Tab.", 
        active: "Amisulpride", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: true,
        package: "30 TAB",
        halfLife: "12 hours",
        sideEffects: ["Weight gain", "hyperprolactinemia", "insomnia", "anxiety", "extrapyramidal symptoms (at high doses)"],
        interactions: ["Other CNS depressants", "Levodopa", "Drugs that prolong QTc (e.g., Erythromycin)"],
        monitor: ["Extrapyramidal symptoms (EPS)", "akathisia", "sedation", "prolactin-related effects (galactorrhea, gynecomastia)"],
        importantInvestigations: ["Prolactin level", "ECG (QTc interval)"]
    },
    { 
        name: "AMIPRIDE 50mg Tab.", 
        active: "Amisulpride", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: true,
        package: "30 TAB",
        halfLife: "12 hours",
        sideEffects: ["Weight gain", "hyperprolactinemia", "insomnia", "anxiety", "extrapyramidal symptoms (at low doses)"],
        interactions: ["Other CNS depressants", "Levodopa", "Drugs that prolong QTc (e.g., Erythromycin)"],
        monitor: ["Extrapyramidal symptoms (EPS)", "akathisia", "sedation", "prolactin-related effects (galactorrhea, gynecomastia)"],
        importantInvestigations: ["Prolactin level", "ECG (QTc interval)"]
    },
    { 
        name: "SOLIAN 200mg Tab.", 
        active: "Amisulpride", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: false,
        package: "30 TAB",
        halfLife: "12 hours",
        sideEffects: ["Weight gain", "hyperprolactinemia", "insomnia", "anxiety", "extrapyramidal symptoms (at high doses)"],
        interactions: ["Other CNS depressants", "Levodopa", "Drugs that prolong QTc (e.g., Erythromycin)"],
        monitor: ["Extrapyramidal symptoms (EPS)", "akathisia", "sedation", "prolactin-related effects (galactorrhea, gynecomastia)"],
        importantInvestigations: ["Prolactin level", "ECG (QTc interval)"]
    },
    { 
        name: "SOLIAN 400mg Tab.", 
        active: "Amisulpride", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: true,
        package: "30 TAB",
        halfLife: "12 hours",
        sideEffects: ["Weight gain", "hyperprolactinemia", "insomnia", "anxiety", "extrapyramidal symptoms (at high doses)"],
        interactions: ["Other CNS depressants", "Levodopa", "Drugs that prolong QTc (e.g., Erythromycin)"],
        monitor: ["Extrapyramidal symptoms (EPS)", "akathisia", "sedation", "prolactin-related effects (galactorrhea, gynecomastia)"],
        importantInvestigations: ["Prolactin level", "ECG (QTc interval)"]
    },
    { 
        name: "TRYTPIZOL 10mg Tab.", 
        active: "Amitriptyline", 
        category: "Tricyclic Antidepressant (TCA)",
        available: true,
        package: "60 TAB",
        halfLife: "7-20 hours",
        sideEffects: ["Sedation", "dry mouth", "constipation", "blurred vision", "orthostatic hypotension", "weight gain"],
        interactions: ["MAOIs", "SSRIs", "Anticholinergics", "CNS depressants", "Drugs that prolong QTc"],
        monitor: ["Sedation", "orthostatic hypotension", "anticholinergic effects (dry mouth, constipation, urinary retention)", "cardiac conduction (monitor for QT prolongation clinically)"],
        importantInvestigations: ["ECG (QTc interval at higher doses)", "baseline in cardiac disease"]
    },
    { 
        name: "TRYTPIZOL 25mg Tab.", 
        active: "Amitriptyline", 
        category: "Tricyclic Antidepressant (TCA)",
        available: true,
        package: "30 TAB",
        halfLife: "7-20 hours",
        sideEffects: ["Sedation", "dry mouth", "constipation", "blurred vision", "orthostatic hypotension", "weight gain"],
        interactions: ["MAOIs", "SSRIs", "Anticholinergics", "CNS depressants", "Drugs that prolong QTc"],
        monitor: ["Sedation", "orthostatic hypotension", "anticholinergic effects (dry mouth, constipation, urinary retention)", "cardiac conduction (monitor for QT prolongation clinically)"],
        importantInvestigations: ["ECG (QTc interval at higher doses)", "baseline in cardiac disease"]
    },
    { 
        name: "ABILIFY MAINTENA 400mg Syring", 
        active: "Aripiprazole", 
        category: "Atypical Antipsychotic (3rd Gen)",
        available: true,
        package: "1 SYRING",
        halfLife: "75 hours",
        sideEffects: ["Akathisia", "headache", "insomnia", "weight gain (less than others)", "nausea", "restlessness"],
        interactions: ["CYP3A4 inducers/inhibitors (e.g., Carbamazepine/Ketoconazole)", "CYP2D6 inhibitors (e.g., Fluoxetine)"],
        monitor: ["Extrapyramidal symptoms (EPS)", "akathisia", "restlessness", "activation of psychosis", "sedation", "weight gain"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "ABILIFY MAINTENA 300mg Syring", 
        active: "Aripiprazole", 
        category: "Atypical Antipsychotic (3rd Gen)",
        available: false,
        package: "1 SYRING",
        halfLife: "75 hours",
        sideEffects: ["Akathisia", "headache", "insomnia", "weight gain (less than others)", "nausea", "restlessness"],
        interactions: ["CYP3A4 inducers/inhibitors (e.g., Carbamazepine/Ketoconazole)", "CYP2D6 inhibitors (e.g., Fluoxetine)"],
        monitor: ["Extrapyramidal symptoms (EPS)", "akathisia", "restlessness", "activation of psychosis", "sedation", "weight gain"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "ABILIFY 10mg Tab.", 
        active: "Aripiprazole", 
        category: "Atypical Antipsychotic (3rd Gen)",
        available: true,
        package: "10 TAB",
        halfLife: "75 hours",
        sideEffects: ["Akathisia", "headache", "insomnia", "weight gain (less than others)", "nausea", "restlessness"],
        interactions: ["CYP3A4 inducers/inhibitors (e.g., Carbamazepine/Ketoconazole)", "CYP2D6 inhibitors (e.g., Fluoxetine)"],
        monitor: ["Extrapyramidal symptoms (EPS)", "akathisia", "restlessness", "activation of psychosis", "sedation", "weight gain"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "ABILIFY 15mg Tab.", 
        active: "Aripiprazole", 
        category: "Atypical Antipsychotic (3rd Gen)",
        available: true,
        package: "10 TAB",
        halfLife: "75 hours",
        sideEffects: ["Akathisia", "headache", "insomnia", "weight gain (less than others)", "nausea", "restlessness"],
        interactions: ["CYP3A4 inducers/inhibitors (e.g., Carbamazepine/Ketoconazole)", "CYP2D6 inhibitors (e.g., Fluoxetine)"],
        monitor: ["Extrapyramidal symptoms (EPS)", "akathisia", "restlessness", "activation of psychosis", "sedation", "weight gain"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "ABILIFY 5mg Tab.", 
        active: "Aripiprazole", 
        category: "Atypical Antipsychotic (3rd Gen)",
        available: true,
        package: "10 TAB",
        halfLife: "75 hours",
        sideEffects: ["Akathisia", "headache", "insomnia", "weight gain (less than others)", "nausea", "restlessness"],
        interactions: ["CYP3A4 inducers/inhibitors (e.g., Carbamazepine/Ketoconazole)", "CYP2D6 inhibitors (e.g., Fluoxetine)"],
        monitor: ["Extrapyramidal symptoms (EPS)", "akathisia", "restlessness", "activation of psychosis", "sedation", "weight gain"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "APILIPEX 10mg Tab.", 
        active: "Aripiprazole", 
        category: "Atypical Antipsychotic (3rd Gen)",
        available: true,
        package: "30 TAB",
        halfLife: "75 hours",
        sideEffects: ["Akathisia", "headache", "insomnia", "weight gain (less than others)", "nausea", "restlessness"],
        interactions: ["CYP3A4 inducers/inhibitors (e.g., Carbamazepine/Ketoconazole)", "CYP2D6 inhibitors (e.g., Fluoxetine)"],
        monitor: ["Extrapyramidal symptoms (EPS)", "akathisia", "restlessness", "activation of psychosis", "sedation", "weight gain"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "APILIPEX 30mg Tab.", 
        active: "Aripiprazole", 
        category: "Atypical Antipsychotic (3rd Gen)",
        available: true,
        package: "30 TAB",
        halfLife: "75 hours",
        sideEffects: ["Akathisia", "headache", "insomnia", "weight gain (less than others)", "nausea", "restlessness"],
        interactions: ["CYP3A4 inducers/inhibitors (e.g., Carbamazepine/Ketoconazole)", "CYP2D6 inhibitors (e.g., Fluoxetine)"],
        monitor: ["Extrapyramidal symptoms (EPS)", "akathisia", "restlessness", "activation of psychosis", "sedation", "weight gain"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "APILIPEX 5mg Tab.", 
        active: "Aripiprazole", 
        category: "Atypical Antipsychotic (3rd Gen)",
        available: true,
        package: "30 TAB",
        halfLife: "75 hours",
        sideEffects: ["Akathisia", "headache", "insomnia", "weight gain (less than others)", "nausea", "restlessness"],
        interactions: ["CYP3A4 inducers/inhibitors (e.g., Carbamazepine/Ketoconazole)", "CYP2D6 inhibitors (e.g., Fluoxetine)"],
        monitor: ["Extrapyramidal symptoms (EPS)", "akathisia", "restlessness", "activation of psychosis", "sedation", "weight gain"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "ARMOWAKE 50mg Tab.", 
        active: "Armodafinil", 
        category: "Wakefulness-Promoting Agent",
        available: true,
        package: "20 TAB",
        halfLife: "10-20 hours",
        sideEffects: ["Headache", "nausea", "anxiety", "insomnia", "dizziness", "dry mouth"],
        interactions: ["CYP3A4 inducers/inhibitors (e.g., Carbamazepine/Ketoconazole)", "Hormonal Contraceptives (reduced efficacy)"],
        monitor: ["Sleep patterns", "alertness", "psychiatric symptoms (anxiety, agitation, mania)", "skin reactions"],
        importantInvestigations: ["None routine"]
    },
    { 
        name: "ASENADIA 10mg Tab.", 
        active: "Asenapine", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: true,
        package: "10 TAB",
        halfLife: "24 hours",
        sideEffects: ["Sedation", "dizziness", "akathisia", "oral hypoesthesia (numbness)", "weight gain", "EPS"],
        interactions: ["CYP1A2 inhibitors (e.g., Fluvoxamine)", "CNS depressants", "Hypertension drugs"],
        monitor: ["Sedation", "EPS", "weight gain", "oral hypoesthesia (numbness after sublingual use)", "dysphagia"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "ASENAPINE 5mg Tab.", 
        active: "Asenapine", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: false,
        package: "30 TAB",
        halfLife: "24 hours",
        sideEffects: ["Sedation", "dizziness", "akathisia", "oral hypoesthesia (numbness)", "weight gain", "EPS"],
        interactions: ["CYP1A2 inhibitors (e.g., Fluvoxamine)", "CNS depressants", "Hypertension drugs"],
        monitor: ["Sedation", "EPS", "weight gain", "oral hypoesthesia (numbness after sublingual use)", "dysphagia"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "ASENAPINE 10mg Tab.", 
        active: "Asenapine", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: false,
        package: "30 TAB",
        halfLife: "24 hours",
        sideEffects: ["Sedation", "dizziness", "akathisia", "oral hypoesthesia (numbness)", "weight gain", "EPS"],
        interactions: ["CYP1A2 inhibitors (e.g., Fluvoxamine)", "CNS depressants", "Hypertension drugs"],
        monitor: ["Sedation", "EPS", "weight gain", "oral hypoesthesia (numbness after sublingual use)", "dysphagia"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "ATOMOX 18mg Cap.", 
        active: "Atomoxetine", 
        category: "Selective Norepinephrine Reuptake Inhibitor (SNRI)",
        available: true,
        package: "30 CAP",
        halfLife: "5.2 hours",
        sideEffects: ["Decreased appetite", "insomnia", "dry mouth", "nausea", "fatigue", "increased heart rate/BP"],
        interactions: ["MAOIs", "Albuterol", "CYP2D6 inhibitors (e.g., Paroxetine, Fluoxetine)"],
        monitor: ["Symptoms of ADHD", "mood changes (suicidal ideation)", "blood pressure", "heart rate", "liver toxicity signs"],
        importantInvestigations: ["Heart rate and blood pressure (baseline and periodic)"]
    },
    { 
        name: "ATOMOX 10mg Cap.", 
        active: "Atomoxetine", 
        category: "Selective Norepinephrine Reuptake Inhibitor (SNRI)",
        available: true,
        package: "30 CAP",
        halfLife: "5.2 hours",
        sideEffects: ["Decreased appetite", "insomnia", "dry mouth", "nausea", "fatigue", "increased heart rate/BP"],
        interactions: ["MAOIs", "Albuterol", "CYP2D6 inhibitors (e.g., Paroxetine, Fluoxetine)"],
        monitor: ["Symptoms of ADHD", "mood changes (suicidal ideation)", "blood pressure", "heart rate", "liver toxicity signs"],
        importantInvestigations: ["Heart rate and blood pressure (baseline and periodic)"]
    },
    { 
        name: "ATOMOX 25mg Cap.", 
        active: "Atomoxetine", 
        category: "Selective Norepinephrine Reuptake Inhibitor (SNRI)",
        available: true,
        package: "30 CAP",
        halfLife: "5.2 hours",
        sideEffects: ["Decreased appetite", "insomnia", "dry mouth", "nausea", "fatigue", "increased heart rate/BP"],
        interactions: ["MAOIs", "Albuterol", "CYP2D6 inhibitors (e.g., Paroxetine, Fluoxetine)"],
        monitor: ["Symptoms of ADHD", "mood changes (suicidal ideation)", "blood pressure", "heart rate", "liver toxicity signs"],
        importantInvestigations: ["Heart rate and blood pressure (baseline and periodic)"]
    },
    { 
        name: "ATOMOX 60mg Cap.", 
        active: "Atomoxetine", 
        category: "Selective Norepinephrine Reuptake Inhibitor (SNRI)",
        available: true,
        package: "30 CAP",
        halfLife: "5.2 hours",
        sideEffects: ["Decreased appetite", "insomnia", "dry mouth", "nausea", "fatigue", "increased heart rate/BP"],
        interactions: ["MAOIs", "Albuterol", "CYP2D6 inhibitors (e.g., Paroxetine, Fluoxetine)"],
        monitor: ["Symptoms of ADHD", "mood changes (suicidal ideation)", "blood pressure", "heart rate", "liver toxicity signs"],
        importantInvestigations: ["Heart rate and blood pressure (baseline and periodic)"]
    },
    { 
        name: "STRATTERA Cap.", 
        active: "Atomoxetine", 
        category: "Selective Norepinephrine Reuptake Inhibitor (SNRI)",
        available: false,
        package: "28 CAP",
        halfLife: "5.2 hours",
        sideEffects: ["Decreased appetite", "insomnia", "dry mouth", "nausea", "fatigue", "increased heart rate/BP"],
        interactions: ["MAOIs", "Albuterol", "CYP2D6 inhibitors (e.g., Paroxetine, Fluoxetine)"],
        monitor: ["Symptoms of ADHD", "mood changes (suicidal ideation)", "blood pressure", "heart rate", "liver toxicity signs"],
        importantInvestigations: ["Heart rate and blood pressure (baseline and periodic)"]
    },
    { 
        name: "COGINTOL 2mg Tab.", 
        active: "Benztropine", 
        category: "Anticholinergic (Anti-Parkinson's)",
        available: true,
        package: "20 TAB",
        halfLife: "18-36 hours",
        sideEffects: ["Dry mouth", "blurred vision", "constipation", "urinary retention", "confusion (in elderly)"],
        interactions: ["Other anticholinergics", "CNS depressants"],
        monitor: ["Anticholinergic side effects (dry mouth, blurred vision, constipation, urinary retention)", "confusion", "tachycardia"],
        importantInvestigations: ["None routine; caution in glaucoma, prostate issues"]
    },
    { 
        name: "ACHTENON 2mg Tab.", 
        active: "Biperidene", 
        category: "Anticholinergic (Anti-Parkinson's)",
        available: true,
        package: "30 TAB",
        halfLife: "~20 hours",
        sideEffects: ["Dry mouth", "blurred vision", "constipation", "urinary retention", "dizziness", "confusion"],
        interactions: ["Other anticholinergics", "CNS depressants"],
        monitor: ["Anticholinergic effects", "sedation", "confusion", "tachycardia", "EPS improvement"],
        importantInvestigations: ["None routine; caution in glaucoma, prostate issues"]
    },
    { 
        name: "NEOPRESSION 2mg Tab.", 
        active: "Brexpiprazole", 
        category: "Atypical Antipsychotic (3rd Gen)",
        available: true,
        package: "20 TAB",
        halfLife: "91 hours",
        sideEffects: ["Weight gain", "akathisia", "headache", "insomnia", "anxiety"],
        interactions: ["CYP3A4/2D6 inducers/inhibitors (e.g., Carbamazepine/Paroxetine)"],
        monitor: ["EPS", "akathisia", "sedation", "weight gain", "mood stabilization"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "NEOPRESSION 4mg Tab.", 
        active: "Brexpiprazole", 
        category: "Atypical Antipsychotic (3rd Gen)",
        available: true,
        package: "20 TAB",
        halfLife: "91 hours",
        sideEffects: ["Weight gain", "akathisia", "headache", "insomnia", "anxiety"],
        interactions: ["CYP3A4/2D6 inducers/inhibitors (e.g., Carbamazepine/Paroxetine)"],
        monitor: ["EPS", "akathisia", "sedation", "weight gain", "mood stabilization"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "WELLINTA SR 150mg Tab.", 
        active: "Bupropion", 
        category: "NDRI (Antidepressant, Smoking Cessation)",
        available: true,
        package: "30 TAB",
        halfLife: "10-14 hours",
        sideEffects: ["Insomnia", "dry mouth", "headache", "nausea", "tremor", "anxiety", "lowers seizure threshold"],
        interactions: ["MAOIs", "drugs that lower seizure threshold", "CYP2D6 substrates (e.g., Tamoxifen)"],
        monitor: ["Seizure threshold (seizure activity)", "insomnia", "agitation", "mood changes", "suicidal ideation"],
        importantInvestigations: ["None routine for mental health use"]
    },
    { 
        name: "WELLBUTRIN SR 150mg Tab.", 
        active: "Bupropion", 
        category: "NDRI (Antidepressant, Smoking Cessation)",
        available: false,
        package: "30 TAB",
        halfLife: "10-14 hours",
        sideEffects: ["Insomnia", "dry mouth", "headache", "nausea", "tremor", "anxiety", "lowers seizure threshold"],
        interactions: ["MAOIs", "drugs that lower seizure threshold", "CYP2D6 substrates (e.g., Tamoxifen)"],
        monitor: ["Seizure threshold (seizure activity)", "insomnia", "agitation", "mood changes", "suicidal ideation"],
        importantInvestigations: ["None routine for mental health use"]
    },
    { 
        name: "SINEMET 25/250mg Tab.", 
        active: "Carbidopa/Levodopa", 
        category: "Dopamine Precursor (Anti-Parkinson's)",
        available: true,
        package: "20 TAB",
        halfLife: "1-3 hours",
        sideEffects: ["Nausea", "dizziness", "orthostatic hypotension", "dyskinesias", "confusion"],
        interactions: ["MAOIs", "Antipsychotics", "Iron supplements", "High-protein meals"],
        monitor: ["Motor fluctuations (on/off periods)", "dyskinesias", "hallucinations", "orthostatic hypotension", "impulse control disorders"],
        importantInvestigations: ["None routine; monitor for symptoms of dyskinesia"]
    },
    { 
        name: "REAGILA 1.5mg Cap.", 
        active: "Cariprazine", 
        category: "Atypical Antipsychotic (3rd Gen)",
        available: true,
        package: "28 CAP",
        halfLife: "2-4 days",
        sideEffects: ["Akathisia", "insomnia", "headache", "constipation", "nausea", "restlessness"],
        interactions: ["Strong CYP3A4 inhibitors/inducers (e.g., Ketoconazole/Carbamazepine)"],
        monitor: ["EPS", "akathisia", "sedation", "mood changes", "weight gain", "QT interval (clinical monitoring for arrhythmia symptoms)"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "REAGILA 3mg Cap.", 
        active: "Cariprazine", 
        category: "Atypical Antipsychotic (3rd Gen)",
        available: true,
        package: "28 CAP",
        halfLife: "2-4 days",
        sideEffects: ["Akathisia", "insomnia", "headache", "constipation", "nausea", "restlessness"],
        interactions: ["Strong CYP3A4 inhibitors/inducers (e.g., Ketoconazole/Carbamazepine)"],
        monitor: ["EPS", "akathisia", "sedation", "mood changes", "weight gain", "QT interval (clinical monitoring for arrhythmia symptoms)"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "REAGILA 4.5mg Cap.", 
        active: "Cariprazine", 
        category: "Atypical Antipsychotic (3rd Gen)",
        available: true,
        package: "28 CAP",
        halfLife: "2-4 days",
        sideEffects: ["Akathisia", "insomnia", "headache", "constipation", "nausea", "restlessness"],
        interactions: ["Strong CYP3A4 inhibitors/inducers (e.g., Ketoconazole/Carbamazepine)"],
        monitor: ["EPS", "akathisia", "sedation", "mood changes", "weight gain", "QT interval (clinical monitoring for arrhythmia symptoms)"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "REAGILA 6mg Cap.", 
        active: "Cariprazine", 
        category: "Atypical Antipsychotic (3rd Gen)",
        available: true,
        package: "28 CAP",
        halfLife: "2-4 days",
        sideEffects: ["Akathisia", "insomnia", "headache", "constipation", "nausea", "restlessness"],
        interactions: ["Strong CYP3A4 inhibitors/inducers (e.g., Ketoconazole/Carbamazepine)"],
        monitor: ["EPS", "akathisia", "sedation", "mood changes", "weight gain", "QT interval (clinical monitoring for arrhythmia symptoms)"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "LIBRAX 30 tablets Tab.", 
        active: "Chlordiazepoxide + Clidinium Bromide", 
        category: "Benzodiazepine + Anticholinergic (Anxiolytic, GI)",
        available: true,
        package: "30 TAB",
        halfLife: "5-30 hours",
        sideEffects: ["Sedation", "dizziness", "dry mouth", "blurred vision", "constipation", "dependence"],
        interactions: ["Alcohol", "Opioids", "Other CNS depressants", "Other anticholinergics"],
        monitor: ["Sedation", "cognitive impairment", "anticholinergic effects", "dependence risk", "constipation"],
        importantInvestigations: ["None routine; caution in elderly"]
    },
    { 
        name: "NEURAZINE 100mg Tab.", 
        active: "Chlorpromazine", 
        category: "Typical Antipsychotic (1st Gen, Phenothiazine)",
        available: true,
        package: "20 TAB",
        halfLife: "8-30 hours",
        sideEffects: ["Sedation", "orthostatic hypotension", "anticholinergic effects", "EPS", "tardive dyskinesia"],
        interactions: ["CNS depressants", "Levodopa", "Drugs that prolong QTc"],
        monitor: ["EPS", "sedation", "orthostatic hypotension", "photosensitivity", "skin reactions"],
        importantInvestigations: ["ECG (QTc interval)", "Prolactin level (if symptomatic)"]
    },
    { 
        name: "DEPRAM 20mg Tab.", 
        active: "Citalopram", 
        category: "SSRI (Antidepressant)",
        available: true,
        package: "20 TAB",
        halfLife: "33 hours",
        sideEffects: ["Nausea", "insomnia", "somnolence", "dry mouth", "diarrhea", "increased sweating"],
        interactions: ["MAOIs", "drugs that prolong QTc (e.g., Pimozide)", "CYP2C19 inhibitors"],
        monitor: ["QT prolongation (symptoms: palpitations, syncope)", "mood changes", "suicidal ideation", "serotonin syndrome"],
        importantInvestigations: ["ECG (QTc interval, esp. with high dose or cardiac risk)"]
    },
    { 
        name: "DEPRAM 40mg Tab.", 
        active: "Citalopram", 
        category: "SSRI (Antidepressant)",
        available: true,
        package: "10 TAB",
        halfLife: "33 hours",
        sideEffects: ["Nausea", "insomnia", "somnolence", "dry mouth", "diarrhea", "increased sweating"],
        interactions: ["MAOIs", "drugs that prolong QTc (e.g., Pimozide)", "CYP2C19 inhibitors"],
        monitor: ["QT prolongation (symptoms: palpitations, syncope)", "mood changes", "suicidal ideation", "serotonin syndrome"],
        importantInvestigations: ["ECG (QTc interval, esp. with high dose or cardiac risk)"]
    },
    { 
        name: "ANAFRANIL 25mg Tab.", 
        active: "Clomipramine", 
        category: "Tricyclic Antidepressant (TCA)",
        available: true,
        package: "30 TAB",
        halfLife: "30-60 hours",
        sideEffects: ["Sedation", "dry mouth", "constipation", "blurred vision", "orthostatic hypotension", "weight gain"],
        interactions: ["MAOIs", "SSRIs", "Anticholinergics", "CNS depressants", "Drugs that prolong QTc"],
        monitor: ["Sedation", "anticholinergic effects", "mood changes", "suicidal ideation", "seizure threshold"],
        importantInvestigations: ["ECG (QTc interval at higher doses)", "baseline in cardiac disease"]
    },
    { 
        name: "ANAFRANIL SR 75mg Tab.", 
        active: "Clomipramine", 
        category: "Tricyclic Antidepressant (TCA)",
        available: true,
        package: "20 TAB",
        halfLife: "30-60 hours",
        sideEffects: ["Sedation", "dry mouth", "constipation", "blurred vision", "orthostatic hypotension", "weight gain"],
        interactions: ["MAOIs", "SSRIs", "Anticholinergics", "CNS depressants", "Drugs that prolong QTc"],
        monitor: ["Sedation", "anticholinergic effects", "mood changes", "suicidal ideation", "seizure threshold"],
        importantInvestigations: ["ECG (QTc interval at higher doses)", "baseline in cardiac disease"]
    },
    { 
        name: "APETRYL 0.5mg Tab.", 
        active: "Clonazepam", 
        category: "Benzodiazepine (Anticonvulsant, Anxiolytic)",
        available: true,
        package: "50 TAB",
        halfLife: "18-50 hours",
        sideEffects: ["Sedation", "dizziness", "fatigue", "ataxia", "coordination problems", "dependence"],
        interactions: ["Alcohol", "Opioids", "Other CNS depressants"],
        monitor: ["Sedation", "ataxia", "cognitive impairment", "dependence", "withdrawal symptoms"],
        importantInvestigations: ["None routine; caution in hepatic impairment"]
    },
    { 
        name: "APETRYL 2mg Tab.", 
        active: "Clonazepam", 
        category: "Benzodiazepine (Anticonvulsant, Anxiolytic)",
        available: true,
        package: "30 TAB",
        halfLife: "18-50 hours",
        sideEffects: ["Sedation", "dizziness", "fatigue", "ataxia", "coordination problems", "dependence"],
        interactions: ["Alcohol", "Opioids", "Other CNS depressants"],
        monitor: ["Sedation", "ataxia", "cognitive impairment", "dependence", "withdrawal symptoms"],
        importantInvestigations: ["None routine; caution in hepatic impairment"]
    },
    { 
        name: "AMOTRIL 0.5mg Tab.", 
        active: "Clonazepam", 
        category: "Benzodiazepine (Anticonvulsant, Anxiolytic)",
        available: false,
        package: "30 TAB",
        halfLife: "18-50 hours",
        sideEffects: ["Sedation", "dizziness", "fatigue", "ataxia", "coordination problems", "dependence"],
        interactions: ["Alcohol", "Opioids", "Other CNS depressants"],
        monitor: ["Sedation", "ataxia", "cognitive impairment", "dependence", "withdrawal symptoms"],
        importantInvestigations: ["None routine; caution in hepatic impairment"]
    },
    { 
        name: "AMOTRIL 2mg Tab.", 
        active: "Clonazepam", 
        category: "Benzodiazepine (Anticonvulsant, Anxiolytic)",
        available: true,
        package: "30 TAB",
        halfLife: "18-50 hours",
        sideEffects: ["Sedation", "dizziness", "fatigue", "ataxia", "coordination problems", "dependence"],
        interactions: ["Alcohol", "Opioids", "Other CNS depressants"],
        monitor: ["Sedation", "ataxia", "cognitive impairment", "dependence", "withdrawal symptoms"],
        importantInvestigations: ["None routine; caution in hepatic impairment"]
    },
    { 
        name: "CLOZAPEX 100mg Tab.", 
        active: "Clozapine", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: true,
        package: "50 TAB",
        halfLife: "12 hours",
        sideEffects: ["Sedation", "sialorrhea (excess saliva)", "weight gain", "tachycardia", "constipation", "agranulocytosis"],
        interactions: ["Bone marrow suppressants", "CNS depressants", "CYP1A2/2D6 inhibitors/inducers"],
        monitor: ["Fever", "sore throat", "lethargy (signs of agranulocytosis)", "sedation", "sialorrhea", "seizures", "constipation", "metabolic changes"],
        importantInvestigations: ["Absolute Neutrophil Count (ANC) - Weekly then monthly", "Weight", "ECG", "LFTs"]
    },
    { 
        name: "CLOZAPEX 25mg Tab.", 
        active: "Clozapine", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: true,
        package: "50 TAB",
        halfLife: "12 hours",
        sideEffects: ["Sedation", "sialorrhea (excess saliva)", "weight gain", "tachycardia", "constipation", "agranulocytosis"],
        interactions: ["Bone marrow suppressants", "CNS depressants", "CYP1A2/2D6 inhibitors/inducers"],
        monitor: ["Fever", "sore throat", "lethargy (signs of agranulocytosis)", "sedation", "sialorrhea", "seizures", "constipation", "metabolic changes"],
        importantInvestigations: ["Absolute Neutrophil Count (ANC) - Weekly then monthly", "Weight", "ECG", "LFTs"]
    },
    { 
        name: "LEPONEX 25mg Tab.", 
        active: "Clozapine", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: false,
        package: "50 TAB",
        halfLife: "12 hours",
        sideEffects: ["Sedation", "sialorrhea (excess saliva)", "weight gain", "tachycardia", "constipation", "agranulocytosis"],
        interactions: ["Bone marrow suppressants", "CNS depressants", "CYP1A2/2D6 inhibitors/inducers"],
        monitor: ["Fever", "sore throat", "lethargy (signs of agranulocytosis)", "sedation", "sialorrhea", "seizures", "constipation", "metabolic changes"],
        importantInvestigations: ["Absolute Neutrophil Count (ANC) - Weekly then monthly", "Weight", "ECG", "LFTs"]
    },
    { 
        name: "LEPONEX 100mg Tab.", 
        active: "Clozapine", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: false,
        package: "50 TAB",
        halfLife: "12 hours",
        sideEffects: ["Sedation", "sialorrhea (excess saliva)", "weight gain", "tachycardia", "constipation", "agranulocytosis"],
        interactions: ["Bone marrow suppressants", "CNS depressants", "CYP1A2/2D6 inhibitors/inducers"],
        monitor: ["Fever", "sore throat", "lethargy (signs of agranulocytosis)", "sedation", "sialorrhea", "seizures", "constipation", "metabolic changes"],
        importantInvestigations: ["Absolute Neutrophil Count (ANC) - Weekly then monthly", "Weight", "ECG", "LFTs"]
    },
    { 
        name: "VENLATROPE 50mg Tab.", 
        active: "Desvenlafaxine", 
        category: "SNRI (Antidepressant)",
        available: true,
        package: "30 TAB",
        halfLife: "11 hours",
        sideEffects: ["Nausea", "headache", "dry mouth", "insomnia", "hyperhidrosis (sweating)", "constipation"],
        interactions: ["MAOIs", "Serotonergic drugs (risk of serotonin syndrome)", "NSAIDs/Aspirin (bleeding risk)"],
        monitor: ["Blood pressure", "mood changes", "suicidal ideation", "serotonin syndrome", "withdrawal symptoms"],
        importantInvestigations: ["Blood pressure (baseline and periodic)"]
    },
    { 
        name: "PRISTIQ 50MG Tab", 
        active: "Desvenlafaxine", 
        category: "SNRI (Antidepressant)",
        available: false,
        package: "30 TAB",
        halfLife: "11 hours",
        sideEffects: ["Nausea", "headache", "dry mouth", "insomnia", "hyperhidrosis (sweating)", "constipation"],
        interactions: ["MAOIs", "Serotonergic drugs (risk of serotonin syndrome)", "NSAIDs/Aspirin (bleeding risk)"],
        monitor: ["Blood pressure", "mood changes", "suicidal ideation", "serotonin syndrome", "withdrawal symptoms"],
        importantInvestigations: ["Blood pressure (baseline and periodic)"]
    },
    { 
        name: "DIVAKOTE 500mg ER Tab.", 
        active: "Divalproex", 
        category: "Anticonvulsant (Mood Stabilizer)",
        available: true,
        package: "20 tab",
        halfLife: "9-16 hours",
        sideEffects: ["Nausea", "sedation", "tremor", "weight gain", "hair loss", "thrombocytopenia", "liver toxicity"],
        interactions: ["Other CNS depressants", "Lamotrigine", "Aspirin/Warfarin", "CYP2C9/UGT inhibitors"],
        monitor: ["Sedation", "tremor", "weight gain", "hair loss", "pancreatitis symptoms (abdominal pain)", "hepatotoxicity signs"],
        importantInvestigations: ["LFTs", "CBC (platelets)", "Valproic Acid level (trough)"]
    },
    { 
        name: "ARICEPT 10mg Tab.", 
        active: "Donepezil", 
        category: "Acetylcholinesterase Inhibitor (For Alzheimer's)",
        available: false,
        package: "14 tab",
        halfLife: "70 hours",
        sideEffects: ["Nausea", "diarrhea", "insomnia", "vomiting", "muscle cramps", "fatigue"],
        interactions: ["Anticholinergics", "Cholinergic agents", "CYP2D6/3A4 inhibitors (e.g., Ketoconazole)"],
        monitor: ["GI tolerability (nausea, vomiting)", "bradycardia", "syncope", "sleep disturbances", "muscle cramps"],
        importantInvestigations: ["None routine; monitor for weight loss, bradycardia"]
    },
    { 
        name: "ARICEPT 5mg Tab.", 
        active: "Donepezil", 
        category: "Acetylcholinesterase Inhibitor (For Alzheimer's)",
        available: true,
        package: "14 tab",
        halfLife: "70 hours",
        sideEffects: ["Nausea", "diarrhea", "insomnia", "vomiting", "muscle cramps", "fatigue"],
        interactions: ["Anticholinergics", "Cholinergic agents", "CYP2D6/3A4 inhibitors (e.g., Ketoconazole)"],
        monitor: ["GI tolerability (nausea, vomiting)", "bradycardia", "syncope", "sleep disturbances", "muscle cramps"],
        importantInvestigations: ["None routine; monitor for weight loss, bradycardia"]
    },
    { 
        name: "CYMBATEX 30mg Cap.", 
        active: "Duloxetine", 
        category: "SNRI (Antidepressant)",
        available: true,
        package: "30 CAP",
        halfLife: "12 hours",
        sideEffects: ["Nausea", "dry mouth", "fatigue", "insomnia", "constipation", "dizziness", "increased sweating"],
        interactions: ["MAOIs", "Serotonergic drugs", "NSAIDs/Aspirin (bleeding risk)", "CYP1A2 inhibitors (e.g., Fluvoxamine)"],
        monitor: ["Blood pressure", "mood changes", "suicidal ideation", "serotonin syndrome", "withdrawal symptoms"],
        importantInvestigations: ["Blood pressure (baseline and periodic)", "LFTs"]
    },
    { 
        name: "CYMBATEX 60mg Cap.", 
        active: "Duloxetine", 
        category: "SNRI (Antidepressant)",
        available: true,
        package: "30 CAP",
        halfLife: "12 hours",
        sideEffects: ["Nausea", "dry mouth", "fatigue", "insomnia", "constipation", "dizziness", "increased sweating"],
        interactions: ["MAOIs", "Serotonergic drugs", "NSAIDs/Aspirin (bleeding risk)", "CYP1A2 inhibitors (e.g., Fluvoxamine)"],
        monitor: ["Blood pressure", "mood changes", "suicidal ideation", "serotonin syndrome", "withdrawal symptoms"],
        importantInvestigations: ["Blood pressure (baseline and periodic)", "LFTs"]
    },
    { 
        name: "CYMBALTA 30mg Cap.", 
        active: "Duloxetine", 
        category: "SNRI (Antidepressant)",
        available: false,
        package: "28 CAP",
        halfLife: "12 hours",
        sideEffects: ["Nausea", "dry mouth", "fatigue", "insomnia", "constipation", "dizziness", "increased sweating"],
        interactions: ["MAOIs", "Serotonergic drugs", "NSAIDs/Aspirin (bleeding risk)", "CYP1A2 inhibitors (e.g., Fluvoxamine)"],
        monitor: ["Blood pressure", "mood changes", "suicidal ideation", "serotonin syndrome", "withdrawal symptoms"],
        importantInvestigations: ["Blood pressure (baseline and periodic)", "LFTs"]
    },
    { 
        name: "CYMBALTA 60mg Cap.", 
        active: "Duloxetine", 
        category: "SNRI (Antidepressant)",
        available: false,
        package: "28 CAP",
        halfLife: "12 hours",
        sideEffects: ["Nausea", "dry mouth", "fatigue", "insomnia", "constipation", "dizziness", "increased sweating"],
        interactions: ["MAOIs", "Serotonergic drugs", "NSAIDs/Aspirin (bleeding risk)", "CYP1A2 inhibitors (e.g., Fluvoxamine)"],
        monitor: ["Blood pressure", "mood changes", "suicidal ideation", "serotonin syndrome", "withdrawal symptoms"],
        importantInvestigations: ["Blood pressure (baseline and periodic)", "LFTs"]
    },
    { 
        name: "CIPRA-PRO 10mg Tab.", 
        active: "Escitalopram", 
        category: "SSRI (Antidepressant)",
        available: true,
        package: "30 TAB",
        halfLife: "27-32 hours",
        sideEffects: ["Nausea", "insomnia", "somnolence", "increased sweating", "fatigue", "ejaculation disorder"],
        interactions: ["MAOIs", "drugs that prolong QTc (e.g., Pimozide)", "Serotonergic drugs"],
        monitor: ["Mood changes", "suicidal ideation", "QT prolongation (palpitations, dizziness)", "serotonin syndrome"],
        importantInvestigations: ["None routine for standard doses"]
    },
    { 
        name: "PHILOZAC 20mg Cap.", 
        active: "Fluoxetine", 
        category: "SSRI (Antidepressant)",
        available: false,
        package: "30 CAP",
        halfLife: "1-3 days",
        sideEffects: ["Nausea", "headache", "insomnia", "anxiety", "nervousness", "sexual dysfunction", "fatigue"],
        interactions: ["MAOIs", "Serotonergic drugs", "CYP2D6 substrates (e.g., Tamoxifen, Codeine)", "Triptans"],
        monitor: ["Mood changes", "suicidal ideation", "activation (insomnia, agitation)", "serotonin syndrome", "weight changes"],
        importantInvestigations: ["None routine for standard doses"]
    },
    { 
        name: "PROZAC 20mg Cap.", 
        active: "Fluoxetine", 
        category: "SSRI (Antidepressant)",
        available: false,
        package: "14 cap",
        halfLife: "1-3 days",
        sideEffects: ["Nausea", "headache", "insomnia", "anxiety", "nervousness", "sexual dysfunction", "fatigue"],
        interactions: ["MAOIs", "Serotonergic drugs", "CYP2D6 substrates (e.g., Tamoxifen, Codeine)", "Triptans"],
        monitor: ["Mood changes", "suicidal ideation", "activation (insomnia, agitation)", "serotonin syndrome", "weight changes"],
        importantInvestigations: ["None routine for standard doses"]
    },
    { 
        name: "DEPREBAN 20mg Cap.", 
        active: "Fluoxetine", 
        category: "SSRI (Antidepressant)",
        available: true,
        package: "10 cap",
        halfLife: "1-3 days",
        sideEffects: ["Nausea", "headache", "insomnia", "anxiety", "nervousness", "sexual dysfunction", "fatigue"],
        interactions: ["MAOIs", "Serotonergic drugs", "CYP2D6 substrates (e.g., Tamoxifen, Codeine)", "Triptans"],
        monitor: ["Mood changes", "suicidal ideation", "activation (insomnia, agitation)", "serotonin syndrome", "weight changes"],
        importantInvestigations: ["None routine for standard doses"]
    },
    { 
        name: "FLUANXOL DEPOT 40mg/2ml Amp.", 
        active: "Flupentixol", 
        category: "Typical Antipsychotic (1st Gen, Thioxanthene)",
        available: true,
        package: "10 AMP",
        halfLife: "30 hours",
        sideEffects: ["Extrapyramidal symptoms (EPS)", "akathisia", "insomnia", "sedation", "anticholinergic effects"],
        interactions: ["Levodopa", "CNS depressants", "Drugs that prolong QTc"],
        monitor: ["EPS", "akathisia", "sedation", "depression activation", "withdrawal symptoms"],
        importantInvestigations: ["ECG (QTc interval)", "Prolactin level (if symptomatic)"]
    },
    { 
        name: "FAVERIN 100mg Tab.", 
        active: "Fluvoxamine", 
        category: "SSRI (Antidepressant)",
        available: true,
        package: "30 TAB",
        halfLife: "15 hours",
        sideEffects: ["Nausea", "somnolence", "headache", "insomnia", "dizziness", "sexual dysfunction", "asthenia"],
        interactions: ["MAOIs", "Serotonergic drugs", "Strong CYP1A2/2C19/3A4 inhibitor (many interactions: Theophylline, Clozapine, Warfarin)"],
        monitor: ["Sedation", "GI upset", "insomnia", "mood changes", "serotonin syndrome"],
        importantInvestigations: ["None routine for standard doses"]
    },
    { 
        name: "FAVERIN 50mg Tab.", 
        active: "Fluvoxamine", 
        category: "SSRI (Antidepressant)",
        available: true,
        package: "60 tab",
        halfLife: "15 hours",
        sideEffects: ["Nausea", "somnolence", "headache", "insomnia", "dizziness", "sexual dysfunction", "asthenia"],
        interactions: ["MAOIs", "Serotonergic drugs", "Strong CYP1A2/2C19/3A4 inhibitor (many interactions: Theophylline, Clozapine, Warfarin)"],
        monitor: ["Sedation", "GI upset", "insomnia", "mood changes", "serotonin syndrome"],
        importantInvestigations: ["None routine for standard doses"]
    },
    { 
        name: "HALDOL DECANOAS 50mg Amp.", 
        active: "Haloperidol", 
        category: "Typical Antipsychotic (1st Gen, Butyrophenone)",
        available: false,
        package: "1 AMP",
        halfLife: "18-52 hours",
        sideEffects: ["Extrapyramidal symptoms (EPS)", "sedation", "restlessness (akathisia)", "hyperprolactinemia", "QTc prolongation"],
        interactions: ["CNS depressants", "Levodopa", "Drugs that prolong QTc (e.g., Amiodarone)", "CYP3A4/2D6 inhibitors"],
        monitor: ["EPS", "sedation", "QT prolongation (palpitations, syncope)", "neuroleptic malignant syndrome (NMS)"],
        importantInvestigations: ["ECG (QTc interval)", "Prolactin level (if symptomatic)"]
    },
    { 
        name: "HALOPERIDOL RETARD 50mg Amp.", 
        active: "Haloperidol", 
        category: "Typical Antipsychotic (1st Gen, Butyrophenone)",
        available: false,
        package: "1 AMP",
        halfLife: "18-52 hours",
        sideEffects: ["Extrapyramidal symptoms (EPS)", "sedation", "restlessness (akathisia)", "hyperprolactinemia", "QTc prolongation"],
        interactions: ["CNS depressants", "Levodopa", "Drugs that prolong QTc (e.g., Amiodarone)", "CYP3A4/2D6 inhibitors"],
        monitor: ["EPS", "sedation", "QT prolongation (palpitations, syncope)", "neuroleptic malignant syndrome (NMS)"],
        importantInvestigations: ["ECG (QTc interval)", "Prolactin level (if symptomatic)"]
    },
    { 
        name: "HALOPERIDOL 5mg/ml Amp.", 
        active: "Haloperidol", 
        category: "Typical Antipsychotic (1st Gen, Butyrophenone)",
        available: true,
        package: "5 AMP",
        halfLife: "18-52 hours",
        sideEffects: ["Extrapyramidal symptoms (EPS)", "sedation", "restlessness (akathisia)", "hyperprolactinemia", "QTc prolongation"],
        interactions: ["CNS depressants", "Levodopa", "Drugs that prolong QTc (e.g., Amiodarone)", "CYP3A4/2D6 inhibitors"],
        monitor: ["EPS", "sedation", "QT prolongation (palpitations, syncope)", "neuroleptic malignant syndrome (NMS)"],
        importantInvestigations: ["ECG (QTc interval)", "Prolactin level (if symptomatic)"]
    },
    { 
        name: "HALONACE 1.5mg Tab.", 
        active: "Haloperidol", 
        category: "Typical Antipsychotic (1st Gen, Butyrophenone)",
        available: true,
        package: "10 TAB",
        halfLife: "18-52 hours",
        sideEffects: ["Extrapyramidal symptoms (EPS)", "sedation", "restlessness (akathisia)", "hyperprolactinemia", "QTc prolongation"],
        interactions: ["CNS depressants", "Levodopa", "Drugs that prolong QTc (e.g., Amiodarone)", "CYP3A4/2D6 inhibitors"],
        monitor: ["EPS", "sedation", "QT prolongation (palpitations, syncope)", "neuroleptic malignant syndrome (NMS)"],
        importantInvestigations: ["ECG (QTc interval)", "Prolactin level (if symptomatic)"]
    },
    { 
        name: "HALONACE 5mg Tab.", 
        active: "Haloperidol", 
        category: "Typical Antipsychotic (1st Gen, Butyrophenone)",
        available: true,
        package: "10 TAB",
        halfLife: "18-52 hours",
        sideEffects: ["Extrapyramidal symptoms (EPS)", "sedation", "restlessness (akathisia)", "hyperprolactinemia", "QTc prolongation"],
        interactions: ["CNS depressants", "Levodopa", "Drugs that prolong QTc (e.g., Amiodarone)", "CYP3A4/2D6 inhibitors"],
        monitor: ["EPS", "sedation", "QT prolongation (palpitations, syncope)", "neuroleptic malignant syndrome (NMS)"],
        importantInvestigations: ["ECG (QTc interval)", "Prolactin level (if symptomatic)"]
    },
    { 
        name: "LAMICTAL 100mg Tab.", 
        active: "Lamotrigine", 
        category: "Anticonvulsant (Mood Stabilizer)",
        available: true,
        package: "30 TAB",
        halfLife: "14-18 hours",
        sideEffects: ["Dizziness", "headache", "diplopia (double vision)", "ataxia", "nausea", "rash (SJS/TEN risk)"],
        interactions: ["Valproate (increases lamotrigine level)", "Carbamazepine/Phenytoin (decrease level)", "Hormonal Contraceptives (may decrease level)"],
        monitor: ["Rash (especially early signs of SJS/TEN)", "mood changes", "coordination"],
        importantInvestigations: ["None routine; monitor for rash meticulously"]
    },
    { 
        name: "LAMICTAL 25mg Tab.", 
        active: "Lamotrigine", 
        category: "Anticonvulsant (Mood Stabilizer)",
        available: true,
        package: "30 TAB",
        halfLife: "14-18 hours",
        sideEffects: ["Dizziness", "headache", "diplopia (double vision)", "ataxia", "nausea", "rash (SJS/TEN risk)"],
        interactions: ["Valproate (increases lamotrigine level)", "Carbamazepine/Phenytoin (decrease level)", "Hormonal Contraceptives (may decrease level)"],
        monitor: ["Rash (especially early signs of SJS/TEN)", "mood changes", "coordination"],
        importantInvestigations: ["None routine; monitor for rash meticulously"]
    },
    { 
        name: "LAMICTAL 50mg Tab.", 
        active: "Lamotrigine", 
        category: "Anticonvulsant (Mood Stabilizer)",
        available: true,
        package: "30 TAB",
        halfLife: "14-18 hours",
        sideEffects: ["Dizziness", "headache", "diplopia (double vision)", "ataxia", "nausea", "rash (SJS/TEN risk)"],
        interactions: ["Valproate (increases lamotrigine level)", "Carbamazepine/Phenytoin (decrease level)", "Hormonal Contraceptives (may decrease level)"],
        monitor: ["Rash (especially early signs of SJS/TEN)", "mood changes", "coordination"],
        importantInvestigations: ["None routine; monitor for rash meticulously"]
    },
    { 
        name: "PRIANIL 400mg Tab.", 
        active: "Lithium", 
        category: "Mood Stabilizer",
        available: false,
        package: "30 TAB",
        halfLife: "18-30 hours",
        sideEffects: ["Nausea", "diarrhea", "tremor", "polyuria", "polydipsia", "weight gain", "hypothyroidism"],
        interactions: ["NSAIDs", "ACEi/ARBs", "Diuretics (can increase levels and toxicity)", "Theophylline", "Caffeine (can decrease levels)"],
        monitor: ["Thirst", "polyuria", "tremor", "weight gain", "cognitive dulling", "diarrhea", "vomiting"],
        importantInvestigations: ["Lithium level", "Renal function (Cr)", "Thyroid Function Tests (TSH)", "Electrolytes", "ECG (if indicated)"]
    },
    { 
        name: "LITHIOMOD 400MG Tab", 
        active: "Lithium", 
        category: "Mood Stabilizer",
        available: true,
        package: "30 TAB",
        halfLife: "18-30 hours",
        sideEffects: ["Nausea", "diarrhea", "tremor", "polyuria", "polydipsia", "weight gain", "hypothyroidism"],
        interactions: ["NSAIDs", "ACEi/ARBs", "Diuretics (can increase levels and toxicity)", "Theophylline", "Caffeine (can decrease levels)"],
        monitor: ["Thirst", "polyuria", "tremor", "weight gain", "cognitive dulling", "diarrhea", "vomiting"],
        importantInvestigations: ["Lithium level", "Renal function (Cr)", "Thyroid Function Tests (TSH)", "Electrolytes", "ECG (if indicated)"]
    },
    { 
        name: "ELBALURAN 20mg Tab.", 
        active: "Lurasidone", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: false,
        package: "30 TAB",
        halfLife: "18 hours",
        sideEffects: ["Somnolence (sleepiness)", "akathisia", "nausea", "parkinsonism", "restlessness"],
        interactions: ["Strong CYP3A4 inhibitors/inducers (e.g., Ketoconazole/Rifampin)", "Grapefruit juice"],
        monitor: ["Sedation", "EPS", "weight gain", "mood changes", "QT prolongation symptoms"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "ELBALURAN 60mg Tab.", 
        active: "Lurasidone", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: false,
        package: "30 TAB",
        halfLife: "18 hours",
        sideEffects: ["Somnolence (sleepiness)", "akathisia", "nausea", "parkinsonism", "restlessness"],
        interactions: ["Strong CYP3A4 inhibitors/inducers (e.g., Ketoconazole/Rifampin)", "Grapefruit juice"],
        monitor: ["Sedation", "EPS", "weight gain", "mood changes", "QT prolongation symptoms"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "TUDASIDONE 40mg Tab.", 
        active: "Lurasidone", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: true,
        package: "20 TAB",
        halfLife: "18 hours",
        sideEffects: ["Somnolence (sleepiness)", "akathisia", "nausea", "parkinsonism", "restlessness"],
        interactions: ["Strong CYP3A4 inhibitors/inducers (e.g., Ketoconazole/Rifampin)", "Grapefruit juice"],
        monitor: ["Sedation", "EPS", "weight gain", "mood changes", "QT prolongation symptoms"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "TUDASIDONE 80mg Tab.", 
        active: "Lurasidone", 
        category: "Atypical Antipsychotic (2nd Gen)",
        available: true,
        package: "20 TAB",
        halfLife: "18 hours",
        sideEffects: ["Somnolence (sleepiness)", "akathisia", "nausea", "parkinsonism", "restlessness"],
        interactions: ["Strong CYP3A4 inhibitors/inducers (e.g., Ketoconazole/Rifampin)", "Grapefruit juice"],
        monitor: ["Sedation", "EPS", "weight gain", "mood changes", "QT prolongation symptoms"],
        importantInvestigations: ["Fasting Blood Glucose", "Lipids (baseline and periodic)"]
    },
    { 
        name: "MELATONIN 5mg Cap.", 
        active: "Melatonin", 
        category: "Hormone (For Sleep)",
        available: true,
        package: "30 TAB",
        halfLife: "20-50 min",
        sideEffects: ["Headache", "dizziness", "nausea", "drowsiness"],
        interactions: ["Anticoagulants (e.g., Warfarin)", "CNS depressants", "Fluvoxamine (increases levels)", "Nifedipine"],
        monitor: ["Drowsiness", "sleep quality", "morning grogginess", "dream changes"],
        importantInvestigations: ["None routine"]
    },
    { 
        name: "EBIXA 10mg Tab.", 
        active: "Memantine", 
        category: "NMDA Receptor Antagonist (For Alzheimer's)",
        available: false,
        package: "28 TAB",
        halfLife: "60-80 hours",
        sideEffects: ["Dizziness", "headache", "constipation", "confusion", "hypertension", "vomiting"],
        interactions: ["Urinary alkalinizers (e.g., Carbonic Anhydrase Inhibitors)", "NMDA antagonists (e.g., Amantadine, Dextromethorphan)"],
        monitor: ["Cognitive function", "behavioral changes", "dizziness", "headache"],
        importantInvestigations: ["None routine; caution in severe renal impairment"]
    },
    { 
        name: "MEMEXA 10mg Tab.", 
        active: "Memantine", 
        category: "NMDA Receptor Antagonist (For Alzheimer's)",
        available: true,
        package: "30 TAB",
        halfLife: "60-80 hours",
        sideEffects: ["Dizziness", "headache", "constipation", "confusion", "hypertension", "vomiting"],
        interactions: ["Urinary alkalinizers (e.g., Carbonic Anhydrase Inhibitors)", "NMDA antagonists (e.g., Amantadine, Dextromethorphan)"],
        monitor: ["Cognitive function", "behavioral changes", "dizziness", "headache"],
        importantInvestigations: ["None routine; caution in severe renal impairment"]
    },
    { 
        name: "MIDAZOLAM 15mg Amp.", 
        active: "Midazolam", 
        category: "Benzodiazepine (Sedative-Hypnotic)",
        available: true,
        package: "1 AMP",
        halfLife: "1.5-2.5 hours",
        sideEffects: ["Respiratory depression", "sedation", "hypotension", "paradoxical reactions (agitation)"],
        interactions: ["CNS depressants (alcohol, opioids, other sedatives)", "CYP3A4 inhibitors (e.g., ketoconazole)"],
        monitor: ["Sedation level", "respiratory depression", "airway patency", "recovery time"],
        importantInvestigations: ["Monitor for respiratory depression, especially with IV use."]
    },
    { 
        name: "MIDAZOLAM 5mg Amp.", 
        active: "Midazolam", 
        category: "Benzodiazepine (Sedative-Hypnotic)",
        available: true,
        package: "1 AMP",
        halfLife: "1.5-2.5 hours",
        sideEffects: ["Respiratory depression", "sedation", "hypotension", "paradoxical reactions (agitation)"],
        interactions: ["CNS depressants (alcohol, opioids, other sedatives)", "CYP3A4 inhibitors (e.g., ketoconazole)"],
        monitor: ["Sedation level", "respiratory depression", "airway patency", "recovery time"],
        importantInvestigations: ["Monitor for respiratory depression, especially with IV use."]
    },
    { 
        name: "DORMICUM AMP", 
        active: "Midazolam", 
        category: "Benzodiazepine (Sedative-Hypnotic)",
        available: false,
        package: "1 AMP",
        halfLife: "1.5-2.5 hours",
        sideEffects: ["Respiratory depression", "sedation", "hypotension", "paradoxical reactions (agitation)"],
        interactions: ["CNS depressants (alcohol, opioids, other sedatives)", "CYP3A4 inhibitors (e.g., ketoconazole)"],
        monitor: ["Sedation level", "respiratory depression", "airway patency", "recovery time"],
        importantInvestigations: ["Monitor for respiratory depression, especially with IV use."]
    },
    { 
        name: "MIRTIMASH 30mg Tab.", 
        active: "Mirtazapine", 
        category: "NaSSA (Atypical Antidepressant)",
        available: true,
        package: "30 TAB",
        halfLife: "20-40 hours",
        sideEffects: ["Sedation", "weight gain", "increased appetite", "dry mouth", "dizziness"],
        interactions: ["CNS depressants (alcohol, benzodiazepines)", "MAOIs (contraindicated)"],
        monitor: ["Sedation", "weight gain", "appetite", "mood changes", "suicidal ideation"],
        importantInvestigations: ["Monitor weight and cholesterol. Sedation is often dose-limiting."]
    },
    { 
        name: "REMERON 30mg Tab.", 
        active: "Mirtazapine", 
        category: "NaSSA (Atypical Antidepressant)",
        available: true,
        package: "10 TAB",
        halfLife: "20-40 hours",
        sideEffects: ["Sedation", "weight gain", "increased appetite", "dry mouth", "dizziness"],
        interactions: ["CNS depressants (alcohol, benzodiazepines)", "MAOIs (contraindicated)"],
        monitor: ["Sedation", "weight gain", "appetite", "mood changes", "suicidal ideation"],
        importantInvestigations: ["Monitor weight and cholesterol. Sedation is often dose-limiting."]
    },
    { 
        name: "BRAVAMAX 200mg Tab.", 
        active: "Modafinil", 
        category: "Wakefulness-Promoting Agent",
        available: true,
        package: "10 TAB",
        halfLife: "12-15 hours",
        sideEffects: ["Headache", "nausea", "nervousness", "insomnia", "anxiety"],
        interactions: ["CYP3A4 inducers/inhibitors (e.g., carbamazepine, ketoconazole)", "hormonal contraceptives (reduced efficacy)"],
        monitor: ["Sleep patterns", "blood pressure", "psychiatric symptoms (anxiety, mania)", "rash"],
        importantInvestigations: ["Monitor for signs of misuse or abuse. Reduces efficacy of birth control."]
    },
    { 
        name: "ANARCOL 50mg Tab.", 
        active: "Naltrexone", 
        category: "Opioid Antagonist",
        available: false,
        package: "30 TAB",
        halfLife: "4 hours",
        sideEffects: ["Nausea", "headache", "dizziness", "insomnia", "anxiety"],
        interactions: ["Opioid analgesics (will block effect)", "hepatotoxic drugs"],
        monitor: ["Psychosocial functioning", "craving reduction", "opioid withdrawal if used in detox"],
        importantInvestigations: ["Patient must be opioid-free before initiation to avoid precipitated withdrawal."]
    },
    { 
        name: "MORFBLOCK 50mg Tab", 
        active: "Naltrexone", 
        category: "Opioid Antagonist",
        available: false,
        package: "10 TAB",
        halfLife: "4 hours",
        sideEffects: ["Nausea", "headache", "dizziness", "insomnia", "anxiety"],
        interactions: ["Opioid analgesics (will block effect)", "hepatotoxic drugs"],
        monitor: ["Psychosocial functioning", "craving reduction", "opioid withdrawal if used in detox"],
        importantInvestigations: ["Patient must be opioid-free before initiation to avoid precipitated withdrawal."]
    },
    { 
        name: "OLAPEX 10mg Tab.", 
        active: "Olanzapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "21-54 hours",
        sideEffects: ["Weight gain", "sedation", "hyperlipidemia", "hyperglycemia", "dizziness"],
        interactions: ["CNS depressants", "antihypertensives (risk of hypotension)", "CYP1A2 inhibitors (e.g., fluvoxamine)"],
        monitor: ["Sedation", "weight gain", "EPS", "metabolic changes", "orthostatic hypotension"],
        importantInvestigations: ["Monitor weight, blood glucose, and lipids regularly."]
    },
    { 
        name: "OLAPEX 5mg Tab.", 
        active: "Olanzapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "21-54 hours",
        sideEffects: ["Weight gain", "sedation", "hyperlipidemia", "hyperglycemia", "dizziness"],
        interactions: ["CNS depressants", "antihypertensives (risk of hypotension)", "CYP1A2 inhibitors (e.g., fluvoxamine)"],
        monitor: ["Sedation", "weight gain", "EPS", "metabolic changes", "orthostatic hypotension"],
        importantInvestigations: ["Monitor weight, blood glucose, and lipids regularly."]
    },
    { 
        name: "ZYPREXA Tab.", 
        active: "Olanzapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: false,
        package: "NA",
        halfLife: "21-54 hours",
        sideEffects: ["Weight gain", "sedation", "hyperlipidemia", "hyperglycemia", "dizziness"],
        interactions: ["CNS depressants", "antihypertensives (risk of hypotension)", "CYP1A2 inhibitors (e.g., fluvoxamine)"],
        monitor: ["Sedation", "weight gain", "EPS", "metabolic changes", "orthostatic hypotension"],
        importantInvestigations: ["Monitor weight, blood glucose, and lipids regularly."]
    },
    { 
        name: "TRILEPTAL 300mg Tab.", 
        active: "Oxcarbazepine", 
        category: "Anticonvulsant",
        available: false,
        package: "50 TAB",
        halfLife: "8-10 hours",
        sideEffects: ["Dizziness", "drowsiness", "diplopia", "fatigue", "hyponatremia", "headache"],
        interactions: ["CYP3A4 substrates (e.g., hormonal contraceptives - reduced efficacy)", "other CNS depressants"],
        monitor: ["Dizziness", "ataxia", "hyponatremia symptoms (headache, confusion)", "rash"],
        importantInvestigations: ["Monitor serum sodium levels, especially early in therapy."]
    },
    { 
        name: "TRILEPTAL 600mg Tab.", 
        active: "Oxcarbazepine", 
        category: "Anticonvulsant",
        available: false,
        package: "50 TAB",
        halfLife: "8-10 hours",
        sideEffects: ["Dizziness", "drowsiness", "diplopia", "fatigue", "hyponatremia", "headache"],
        interactions: ["CYP3A4 substrates (e.g., hormonal contraceptives - reduced efficacy)", "other CNS depressants"],
        monitor: ["Dizziness", "ataxia", "hyponatremia symptoms (headache, confusion)", "rash"],
        importantInvestigations: ["Monitor serum sodium levels, especially early in therapy."]
    },
    { 
        name: "OXALEPTAL 300mg Tab.", 
        active: "Oxcarbazepine", 
        category: "Anticonvulsant",
        available: true,
        package: "30 TAB",
        halfLife: "8-10 hours",
        sideEffects: ["Dizziness", "drowsiness", "diplopia", "fatigue", "hyponatremia", "headache"],
        interactions: ["CYP3A4 substrates (e.g., hormonal contraceptives - reduced efficacy)", "other CNS depressants"],
        monitor: ["Dizziness", "ataxia", "hyponatremia symptoms (headache, confusion)", "rash"],
        importantInvestigations: ["Monitor serum sodium levels, especially early in therapy."]
    },
    { 
        name: "OXALEPTAL 600mg Tab.", 
        active: "Oxcarbazepine", 
        category: "Anticonvulsant",
        available: true,
        package: "30 TAB",
        halfLife: "8-10 hours",
        sideEffects: ["Dizziness", "drowsiness", "diplopia", "fatigue", "hyponatremia", "headache"],
        interactions: ["CYP3A4 substrates (e.g., hormonal contraceptives - reduced efficacy)", "other CNS depressants"],
        monitor: ["Dizziness", "ataxia", "hyponatremia symptoms (headache, confusion)", "rash"],
        importantInvestigations: ["Monitor serum sodium levels, especially early in therapy."]
    },
    { 
        name: "INVEGA SUSTENNA 100mg Syring", 
        active: "Paliperidone", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "1 SYRING",
        halfLife: "23 hours",
        sideEffects: ["Extrapyramidal symptoms", "tachycardia", "weight gain", "hyperprolactinemia", "sedation"],
        interactions: ["Other CNS depressants", "drugs that prolong QT interval", "levodopa (antagonizes effect)"],
        monitor: ["Sedation", "EPS", "akathisia", "weight gain", "mood stabilization"],
        importantInvestigations: ["Monitor for EPS and akathisia. Administer by deep IM gluteal injection."]
    },
    { 
        name: "INVEGA SUSTENNA 150mg Syring", 
        active: "Paliperidone", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "1 SYRING",
        halfLife: "23 hours",
        sideEffects: ["Extrapyramidal symptoms", "tachycardia", "weight gain", "hyperprolactinemia", "sedation"],
        interactions: ["Other CNS depressants", "drugs that prolong QT interval", "levodopa (antagonizes effect)"],
        monitor: ["Sedation", "EPS", "akathisia", "weight gain", "mood stabilization"],
        importantInvestigations: ["Monitor for EPS and akathisia. Administer by deep IM gluteal injection."]
    },
    { 
        name: "INVEGA SUSTENNA 75mg Syring", 
        active: "Paliperidone", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: false,
        package: "1 SYRING",
        halfLife: "23 hours",
        sideEffects: ["Extrapyramidal symptoms", "tachycardia", "weight gain", "hyperprolactinemia", "sedation"],
        interactions: ["Other CNS depressants", "drugs that prolong QT interval", "levodopa (antagonizes effect)"],
        monitor: ["Sedation", "EPS", "akathisia", "weight gain", "mood stabilization"],
        importantInvestigations: ["Monitor for EPS and akathisia. Administer by deep IM gluteal injection."]
    },
    { 
        name: "TREVICTA 350mg Syring", 
        active: "Paliperidone", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "1 SYRING",
        halfLife: "23 hours",
        sideEffects: ["Extrapyramidal symptoms", "tachycardia", "weight gain", "hyperprolactinemia", "sedation"],
        interactions: ["Other CNS depressants", "drugs that prolong QT interval", "levodopa (antagonizes effect)"],
        monitor: ["Sedation", "EPS", "akathisia", "weight gain", "mood stabilization"],
        importantInvestigations: ["Monitor for EPS and akathisia. 3-month formulation. Administer by deep IM gluteal injection."]
    },
    { 
        name: "TREVICTA 525mg Syring", 
        active: "Paliperidone", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: false,
        package: "1 SYRING",
        halfLife: "23 hours",
        sideEffects: ["Extrapyramidal symptoms", "tachycardia", "weight gain", "hyperprolactinemia", "sedation"],
        interactions: ["Other CNS depressants", "drugs that prolong QT interval", "levodopa (antagonizes effect)"],
        monitor: ["Sedation", "EPS", "akathisia", "weight gain", "mood stabilization"],
        importantInvestigations: ["Monitor for EPS and akathisia. 3-month formulation. Administer by deep IM gluteal injection."]
    },
    { 
        name: "INVEGA 3mg Tab.", 
        active: "Paliperidone", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "7 TAB",
        halfLife: "23 hours",
        sideEffects: ["Extrapyramidal symptoms", "tachycardia", "weight gain", "hyperprolactinemia", "sedation"],
        interactions: ["Other CNS depressants", "drugs that prolong QT interval", "levodopa (antagonizes effect)"],
        monitor: ["Sedation", "EPS", "akathisia", "weight gain", "mood stabilization"],
        importantInvestigations: ["Do not crush or chew tablet (ER formulation). Monitor for EPS."]
    },
    { 
        name: "INVEGA 6mg Tab.", 
        active: "Paliperidone", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: false,
        package: "7 TAB",
        halfLife: "23 hours",
        sideEffects: ["Extrapyramidal symptoms", "tachycardia", "weight gain", "hyperprolactinemia", "sedation"],
        interactions: ["Other CNS depressants", "drugs that prolong QT interval", "levodopa (antagonizes effect)"],
        monitor: ["Sedation", "EPS", "akathisia", "weight gain", "mood stabilization"],
        importantInvestigations: ["Do not crush or chew tablet (ER formulation). Monitor for EPS."]
    },
    { 
        name: "PAROXETINE 12.5mg CR Tab.", 
        active: "Paroxetine", 
        category: "SSRI (Antidepressant)",
        available: false,
        package: "30 TAB",
        halfLife: "21 hours",
        sideEffects: ["Nausea", "somnolence", "sweating", "sexual dysfunction", "asthenia", "insomnia"],
        interactions: ["MAOIs (contraindicated)", "serotonergic drugs", "NSAIDs/aspirin (increased bleed risk)", "CYP2D6 substrates"],
        monitor: ["Sedation", "mood changes", "suicidal ideation", "sexual dysfunction", "withdrawal symptoms"],
        importantInvestigations: ["Strong CYP2D6 inhibitor. Has more anticholinergic effects than other SSRIs."]
    },
    { 
        name: "PAROXETINE 25mg CR Tab.", 
        active: "Paroxetine", 
        category: "SSRI (Antidepressant)",
        available: true,
        package: "30 TAB",
        halfLife: "21 hours",
        sideEffects: ["Nausea", "somnolence", "sweating", "sexual dysfunction", "asthenia", "insomnia"],
        interactions: ["MAOIs (contraindicated)", "serotonergic drugs", "NSAIDs/aspirin (increased bleed risk)", "CYP2D6 substrates"],
        monitor: ["Sedation", "mood changes", "suicidal ideation", "sexual dysfunction", "withdrawal symptoms"],
        importantInvestigations: ["Strong CYP2D6 inhibitor. Has more anticholinergic effects than other SSRIs."]
    },
    { 
        name: "PAROXETINE 37.5mg CR Tab.", 
        active: "Paroxetine", 
        category: "SSRI (Antidepressant)",
        available: false,
        package: "30 TAB",
        halfLife: "21 hours",
        sideEffects: ["Nausea", "somnolence", "sweating", "sexual dysfunction", "asthenia", "insomnia"],
        interactions: ["MAOIs (contraindicated)", "serotonergic drugs", "NSAIDs/aspirin (increased bleed risk)", "CYP2D6 substrates"],
        monitor: ["Sedation", "mood changes", "suicidal ideation", "sexual dysfunction", "withdrawal symptoms"],
        importantInvestigations: ["Strong CYP2D6 inhibitor. Has more anticholinergic effects than other SSRIs."]
    },
    { 
        name: "SEROXAT CR 12.5mg Tab.", 
        active: "Paroxetine", 
        category: "SSRI (Antidepressant)",
        available: true,
        package: "30 TAB",
        halfLife: "21 hours",
        sideEffects: ["Nausea", "somnolence", "sweating", "sexual dysfunction", "asthenia", "insomnia"],
        interactions: ["MAOIs (contraindicated)", "serotonergic drugs", "NSAIDs/aspirin (increased bleed risk)", "CYP2D6 substrates"],
        monitor: ["Sedation", "mood changes", "suicidal ideation", "sexual dysfunction", "withdrawal symptoms"],
        importantInvestigations: ["Strong CYP2D6 inhibitor. Has more anticholinergic effects than other SSRIs."]
    },
    { 
        name: "SEROXAT CR 25mg Tab.", 
        active: "Paroxetine", 
        category: "SSRI (Antidepressant)",
        available: true,
        package: "30 TAB",
        halfLife: "21 hours",
        sideEffects: ["Nausea", "somnolence", "sweating", "sexual dysfunction", "asthenia", "insomnia"],
        interactions: ["MAOIs (contraindicated)", "serotonergic drugs", "NSAIDs/aspirin (increased bleed risk)", "CYP2D6 substrates"],
        monitor: ["Sedation", "mood changes", "suicidal ideation", "sexual dysfunction", "withdrawal symptoms"],
        importantInvestigations: ["Strong CYP2D6 inhibitor. Has more anticholinergic effects than other SSRIs."]
    },
    { 
        name: "PHENYTIN 100mg/2ml Amp.", 
        active: "Phenytoin", 
        category: "Hydantoin (Anticonvulsant)",
        available: true,
        package: "1 AMP",
        halfLife: "6-24 hours",
        sideEffects: ["Nystagmus", "ataxia", "slurred speech", "diplopia", "gingival hyperplasia", "rash"],
        interactions: ["CYP450 inducers (affects many drugs)", "warfarin", "oral contraceptives (reduced efficacy)", "CNS depressants"],
        monitor: ["Nystagmus", "ataxia", "gingival hyperplasia", "rash", "coarsening of facial features"],
        importantInvestigations: ["Therapeutic drug monitoring required. Highly protein-bound."]
    },
    { 
        name: "PHENYTIN 250mg/5ml Amp.", 
        active: "Phenytoin", 
        category: "Hydantoin (Anticonvulsant)",
        available: true,
        package: "10 AMP",
        halfLife: "6-24 hours",
        sideEffects: ["Nystagmus", "ataxia", "slurred speech", "diplopia", "gingival hyperplasia", "rash"],
        interactions: ["CYP450 inducers (affects many drugs)", "warfarin", "oral contraceptives (reduced efficacy)", "CNS depressants"],
        monitor: ["Nystagmus", "ataxia", "gingival hyperplasia", "rash", "coarsening of facial features"],
        importantInvestigations: ["Therapeutic drug monitoring required. Highly protein-bound."]
    },
    { 
        name: "PHENYTIN 100mg Cap.", 
        active: "Phenytoin", 
        category: "Hydantoin (Anticonvulsant)",
        available: true,
        package: "50 CAP",
        halfLife: "6-24 hours",
        sideEffects: ["Nystagmus", "ataxia", "slurred speech", "diplopia", "gingival hyperplasia", "rash"],
        interactions: ["CYP450 inducers (affects many drugs)", "warfarin", "oral contraceptives (reduced efficacy)", "CNS depressants"],
        monitor: ["Nystagmus", "ataxia", "gingival hyperplasia", "rash", "coarsening of facial features"],
        importantInvestigations: ["Therapeutic drug monitoring required. Highly protein-bound."]
    },
    { 
        name: "PHENYTIN 50mg Cap.", 
        active: "Phenytoin", 
        category: "Hydantoin (Anticonvulsant)",
        available: true,
        package: "50 CAP",
        halfLife: "6-24 hours",
        sideEffects: ["Nystagmus", "ataxia", "slurred speech", "diplopia", "gingival hyperplasia", "rash"],
        interactions: ["CYP450 inducers (affects many drugs)", "warfarin", "oral contraceptives (reduced efficacy)", "CNS depressants"],
        monitor: ["Nystagmus", "ataxia", "gingival hyperplasia", "rash", "coarsening of facial features"],
        importantInvestigations: ["Therapeutic drug monitoring required. Highly protein-bound."]
    },
    { 
        name: "STIMULAN 400mg Cap.", 
        active: "Piracetam", 
        category: "Nootropic",
        available: true,
        package: "30 CAP",
        halfLife: "5-6 hours",
        sideEffects: ["Nervousness", "insomnia", "weight gain", "depression", "hyperkinesia", "drowsiness"],
        interactions: ["Anticoagulants/antiplatelets (increased risk of bleeding)", "thyroid hormones"],
        monitor: ["Neurocognitive function", "agitation", "nervousness", "insomnia"],
        importantInvestigations: ["Monitor for CNS side effects. Use with caution in those with bleeding risk."]
    },
    { 
        name: "STIMULAN 800mg Tab.", 
        active: "Piracetam", 
        category: "Nootropic",
        available: true,
        package: "30 TAB",
        halfLife: "5-6 hours",
        sideEffects: ["Nervousness", "insomnia", "weight gain", "depression", "hyperkinesia", "drowsiness"],
        interactions: ["Anticoagulants/antiplatelets (increased risk of bleeding)", "thyroid hormones"],
        monitor: ["Neurocognitive function", "agitation", "nervousness", "insomnia"],
        importantInvestigations: ["Monitor for CNS side effects. Use with caution in those with bleeding risk."]
    },
    { 
        name: "OXITROPIL 1200mg Tab.", 
        active: "Piracetam", 
        category: "Nootropic",
        available: true,
        package: "60 TAB",
        halfLife: "5-6 hours",
        sideEffects: ["Nervousness", "insomnia", "weight gain", "depression", "hyperkinesia", "drowsiness"],
        interactions: ["Anticoagulants/antiplatelets (increased risk of bleeding)", "thyroid hormones"],
        monitor: ["Neurocognitive function", "agitation", "nervousness", "insomnia"],
        importantInvestigations: ["Monitor for CNS side effects. Use with caution in those with bleeding risk."]
    },
    { 
        name: "RAMIXOLE 0.25mg Tab.", 
        active: "Pramipexol", 
        category: "Dopamine Agonist",
        available: true,
        package: "30 TAB",
        halfLife: "8-12 hours",
        sideEffects: ["Nausea", "dizziness", "somnolence", "insomnia", "constipation", "impulse control disorders"],
        interactions: ["Antipsychotics (may diminish effect)", "other CNS depressants", "drugs excreted renally"],
        monitor: ["Sleep attacks", "impulse control disorders (gambling, hypersexuality)", "orthostatic hypotension", "nausea"],
        importantInvestigations: ["Warn about potential for impulsive behaviors (gambling, shopping, etc.). Titrate slowly."]
    },
    { 
        name: "RAMIXOLE 1mg Tab.", 
        active: "Pramipexol", 
        category: "Dopamine Agonist",
        available: false,
        package: "30 TAB",
        halfLife: "8-12 hours",
        sideEffects: ["Nausea", "dizziness", "somnolence", "insomnia", "constipation", "impulse control disorders"],
        interactions: ["Antipsychotics (may diminish effect)", "other CNS depressants", "drugs excreted renally"],
        monitor: ["Sleep attacks", "impulse control disorders (gambling, hypersexuality)", "orthostatic hypotension", "nausea"],
        importantInvestigations: ["Warn about potential for impulsive behaviors (gambling, shopping, etc.). Titrate slowly."]
    },
    { 
        name: "QUITAPEX 100mg Tab.", 
        active: "Quetiapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "6 hours",
        sideEffects: ["Sedation", "dry mouth", "dizziness", "weight gain", "constipation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["Sedation", "orthostatic hypotension", "weight gain", "metabolic changes", "cataracts (long-term)"],
        importantInvestigations: ["Monitor weight, blood glucose, lipids, and blood pressure. Risk of cataract (monitor eye exams)."]
    },
    { 
        name: "QUITAPEX 200mg Tab.", 
        active: "Quetiapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "6 hours",
        sideEffects: ["Sedation", "dry mouth", "dizziness", "weight gain", "constipation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["Sedation", "orthostatic hypotension", "weight gain", "metabolic changes", "cataracts (long-term)"],
        importantInvestigations: ["Monitor weight, blood glucose, lipids, and blood pressure. Risk of cataract (monitor eye exams)."]
    },
    { 
        name: "QUITAPEX 25mg Tab.", 
        active: "Quetiapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "6 hours",
        sideEffects: ["Sedation", "dry mouth", "dizziness", "weight gain", "constipation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["Sedation", "orthostatic hypotension", "weight gain", "metabolic changes", "cataracts (long-term)"],
        importantInvestigations: ["Monitor weight, blood glucose, lipids, and blood pressure. Risk of cataract (monitor eye exams)."]
    },
    { 
        name: "QUITCOOL 150 XR Tab.", 
        active: "Quetiapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "6 hours",
        sideEffects: ["Sedation", "dry mouth", "dizziness", "weight gain", "constipation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["Sedation", "orthostatic hypotension", "weight gain", "metabolic changes", "cataracts (long-term)"],
        importantInvestigations: ["Do not crush or chew. Monitor weight, blood glucose, lipids. Higher QTc risk than IR."]
    },
    { 
        name: "QUITCOOL 200 XR Tab.", 
        active: "Quetiapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "6 hours",
        sideEffects: ["Sedation", "dry mouth", "dizziness", "weight gain", "constipation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["Sedation", "orthostatic hypotension", "weight gain", "metabolic changes", "cataracts (long-term)"],
        importantInvestigations: ["Do not crush or chew. Monitor weight, blood glucose, lipids. Higher QTc risk than IR."]
    },
    { 
        name: "QUETIAZIC 300 XR Tab.", 
        active: "Quetiapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "6 hours",
        sideEffects: ["Sedation", "dry mouth", "dizziness", "weight gain", "constipation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["Sedation", "orthostatic hypotension", "weight gain", "metabolic changes", "cataracts (long-term)"],
        importantInvestigations: ["Do not crush or chew. Monitor weight, blood glucose, lipids. Higher QTc risk than IR."]
    },
    {
        name: "QUITCOOL 300 XR Tab.", 
        active: "Quetiapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: false,
        package: "30 TAB",
        halfLife: "6 hours",
        sideEffects: ["Sedation", "dry mouth", "dizziness", "weight gain", "constipation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["Sedation", "orthostatic hypotension", "weight gain", "metabolic changes", "cataracts (long-term)"],
        importantInvestigations: ["Do not crush or chew. Monitor weight, blood glucose, lipids. Higher QTc risk than IR."]
    },
    { 
        name: "QUITCOOL 400 XR Tab.", 
        active: "Quetiapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "6 hours",
        sideEffects: ["Sedation", "dry mouth", "dizziness", "weight gain", "constipation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["Sedation", "orthostatic hypotension", "weight gain", "metabolic changes", "cataracts (long-term)"],
        importantInvestigations: ["Do not crush or chew. Monitor weight, blood glucose, lipids. Higher QTc risk than IR."]
    },
    { 
        name: "QUITCOOL 50 XR Tab.", 
        active: "Quetiapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "6 hours",
        sideEffects: ["Sedation", "dry mouth", "dizziness", "weight gain", "constipation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["Sedation", "orthostatic hypotension", "weight gain", "metabolic changes", "cataracts (long-term)"],
        importantInvestigations: ["Do not crush or chew. Monitor weight, blood glucose, lipids. Higher QTc risk than IR."]
    },
    { 
        name: "SEROQUEL 100mg Tab.", 
        active: "Quetiapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "6 hours",
        sideEffects: ["Sedation", "dry mouth", "dizziness", "weight gain", "constipation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["Sedation", "orthostatic hypotension", "weight gain", "metabolic changes", "cataracts (long-term)"],
        importantInvestigations: ["Monitor weight, blood glucose, lipids, and blood pressure. Risk of cataract (monitor eye exams)."]
    },
    { 
        name: "SEROQUEL 200mg Tab.", 
        active: "Quetiapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "6 hours",
        sideEffects: ["Sedation", "dry mouth", "dizziness", "weight gain", "constipation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["Sedation", "orthostatic hypotension", "weight gain", "metabolic changes", "cataracts (long-term)"],
        importantInvestigations: ["Monitor weight, blood glucose, lipids, and blood pressure. Risk of cataract (monitor eye exams)."]
    },
    { 
        name: "SEROQUEL 25mg Tab.", 
        active: "Quetiapine", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "6 hours",
        sideEffects: ["Sedation", "dry mouth", "dizziness", "weight gain", "constipation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["Sedation", "orthostatic hypotension", "weight gain", "metabolic changes", "cataracts (long-term)"],
        importantInvestigations: ["Monitor weight, blood glucose, lipids, and blood pressure. Risk of cataract (monitor eye exams)."]
    },
    { 
        name: "APEXIDONE 0.5mg Tab.", 
        active: "Risperidone", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "3-20 hours",
        sideEffects: ["Extrapyramidal symptoms", "hyperprolactinemia", "weight gain", "sedation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "drugs that prolong QT interval", "levodopa (antagonizes effect)", "CYP2D6 inhibitors"],
        monitor: ["Sedation", "EPS", "akathisia", "weight gain", "prolactin elevation symptoms"],
        importantInvestigations: ["Monitor for EPS and akathisia. Dose-dependent EPS risk."]
    },
    { 
        name: "APEXIDONE 1mg Tab.", 
        active: "Risperidone", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "20 TAB",
        halfLife: "3-20 hours",
        sideEffects: ["Extrapyramidal symptoms", "hyperprolactinemia", "weight gain", "sedation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "drugs that prolong QT interval", "levodopa (antagonizes effect)", "CYP2D6 inhibitors"],
        monitor: ["Sedation", "EPS", "akathisia", "weight gain", "prolactin elevation symptoms"],
        importantInvestigations: ["Monitor for EPS and akathisia. Dose-dependent EPS risk."]
    },
    { 
        name: "APEXIDONE 2mg Tab.", 
        active: "Risperidone", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "20 TAB",
        halfLife: "3-20 hours",
        sideEffects: ["Extrapyramidal symptoms", "hyperprolactinemia", "weight gain", "sedation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "drugs that prolong QT interval", "levodopa (antagonizes effect)", "CYP2D6 inhibitors"],
        monitor: ["Sedation", "EPS", "akathisia", "weight gain", "prolactin elevation symptoms"],
        importantInvestigations: ["Monitor for EPS and akathisia. Dose-dependent EPS risk."]
    },
    { 
        name: "APEXIDONE 3mg Tab.", 
        active: "Risperidone", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "3-20 hours",
        sideEffects: ["Extrapyramidal symptoms", "hyperprolactinemia", "weight gain", "sedation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "drugs that prolong QT interval", "levodopa (antagonizes effect)", "CYP2D6 inhibitors"],
        monitor: ["Sedation", "EPS", "akathisia", "weight gain", "prolactin elevation symptoms"],
        importantInvestigations: ["Monitor for EPS and akathisia. Dose-dependent EPS risk."]
    },
    { 
        name: "APEXIDONE 4mg Tab.", 
        active: "Risperidone", 
        category: "Atypical Antipsychotic (Second Generation)",
        available: true,
        package: "30 TAB",
        halfLife: "3-20 hours",
        sideEffects: ["Extrapyramidal symptoms", "hyperprolactinemia", "weight gain", "sedation", "orthostatic hypotension"],
        interactions: ["CNS depressants", "drugs that prolong QT interval", "levodopa (antagonizes effect)", "CYP2D6 inhibitors"],
        monitor: ["Sedation", "EPS", "akathisia", "weight gain", "prolactin elevation symptoms"],
        importantInvestigations: ["Monitor for EPS and akathisia. Dose-dependent EPS risk."]
    },
    { 
        name: "LUSTRAL 50mg Tab.", 
        active: "Sertraline", 
        category: "SSRI (Antidepressant)",
        available: true,
        package: "20 TAB",
        halfLife: "26 hours",
        sideEffects: ["Nausea", "diarrhea", "insomnia", "sexual dysfunction", "headache", "dry mouth"],
        interactions: ["MAOIs (contraindicated)", "serotonergic drugs", "NSAIDs/aspirin (increased bleed risk)", "CYP2D6 substrates"],
        monitor: ["Mood changes", "suicidal ideation", "GI symptoms", "activation", "withdrawal"],
        importantInvestigations: ["Can be more activating than other SSRIs. Usually taken in the morning."]
    },
    { 
        name: "MOODAPEX 50mg Tab.", 
        active: "Sertraline", 
        category: "SSRI (Antidepressant)",
        available: true,
        package: "30 TAB",
        halfLife: "26 hours",
        sideEffects: ["Nausea", "diarrhea", "insomnia", "sexual dysfunction", "headache", "dry mouth"],
        interactions: ["MAOIs (contraindicated)", "serotonergic drugs", "NSAIDs/aspirin (increased bleed risk)", "CYP2D6 substrates"],
        monitor: ["Mood changes", "suicidal ideation", "GI symptoms", "activation", "withdrawal"],
        importantInvestigations: ["Can be more activating than other SSRIs. Usually taken in the morning."]
    },
    { 
        name: "DOGMATIL 50mg Cap.", 
        active: "Sulpiride", 
        category: "Typical Antipsychotic (First Generation)",
        available: true,
        package: "30 CAP",
        halfLife: "6-15 hours",
        sideEffects: ["Extrapyramidal symptoms", "hyperprolactinemia", "weight gain", "insomnia", "agitation"],
        interactions: ["Other CNS depressants", "levodopa (antagonizes effect)", "antihypertensives"],
        monitor: ["EPS", "akathisia", "sedation", "prolactin-related effects"],
        importantInvestigations: ["Monitor for EPS. Higher risk of hyperprolactinemia compared to some other antipsychotics."]
    },
    { 
        name: "DOGMATIL FORTE 200mg Tab.", 
        active: "Sulpiride", 
        category: "Typical Antipsychotic (First Generation)",
        available: true,
        package: "10 TAB",
        halfLife: "6-15 hours",
        sideEffects: ["Extrapyramidal symptoms", "hyperprolactinemia", "weight gain", "insomnia", "agitation"],
        interactions: ["Other CNS depressants", "levodopa (antagonizes effect)", "antihypertensives"],
        monitor: ["EPS", "akathisia", "sedation", "prolactin-related effects"],
        importantInvestigations: ["Monitor for EPS. Higher risk of hyperprolactinemia compared to some other antipsychotics."]
    },
    { 
        name: "TOPAMAX 100mg Tab.", 
        active: "Topiramate", 
        category: "Anticonvulsant",
        available: false,
        package: "60 TAB",
        halfLife: "21 hours",
        sideEffects: ["Paresthesia", "weight loss", "cognitive impairment", "fatigue", "nausea", "taste alteration"],
        interactions: ["Other CNS depressants", "carbonic anhydrase inhibitors (increased kidney stone risk)", "oral contraceptives (reduced efficacy)"],
        monitor: ["Cognitive effects (word-finding difficulty)", "paresthesia", "weight loss", "glaucoma symptoms (eye pain, vision changes)"],
        importantInvestigations: ["Monitor for cognitive slowing and word-finding difficulty. Encourage hydration."]
    },
    { 
        name: "TOPAMAX 25mg Tab.", 
        active: "Topiramate", 
        category: "Anticonvulsant",
        available: false,
        package: "60 TAB",
        halfLife: "21 hours",
        sideEffects: ["Paresthesia", "weight loss", "cognitive impairment", "fatigue", "nausea", "taste alteration"],
        interactions: ["Other CNS depressants", "carbonic anhydrase inhibitors (increased kidney stone risk)", "oral contraceptives (reduced efficacy)"],
        monitor: ["Cognitive effects (word-finding difficulty)", "paresthesia", "weight loss", "glaucoma symptoms (eye pain, vision changes)"],
        importantInvestigations: ["Monitor for cognitive slowing and word-finding difficulty. Encourage hydration."]
    },
    { 
        name: "TOPIRAMATE 25mg Tab", 
        active: "Topiramate", 
        category: "Anticonvulsant",
        available: true,
        package: "30 TAB",
        halfLife: "21 hours",
        sideEffects: ["Paresthesia", "weight loss", "cognitive impairment", "fatigue", "nausea", "taste alteration"],
        interactions: ["Other CNS depressants", "carbonic anhydrase inhibitors (increased kidney stone risk)", "oral contraceptives (reduced efficacy)"],
        monitor: ["Cognitive effects (word-finding difficulty)", "paresthesia", "weight loss", "glaucoma symptoms (eye pain, vision changes)"],
        importantInvestigations: ["Monitor for cognitive slowing and word-finding difficulty. Encourage hydration."]
    },
    { 
        name: "TOPIRAMATE 100mg Tab", 
        active: "Topiramate", 
        category: "Anticonvulsant",
        available: true,
        package: "10 TAB",
        halfLife: "21 hours",
        sideEffects: ["Paresthesia", "weight loss", "cognitive impairment", "fatigue", "nausea", "taste alteration"],
        interactions: ["Other CNS depressants", "carbonic anhydrase inhibitors (increased kidney stone risk)", "oral contraceptives (reduced efficacy)"],
        monitor: ["Cognitive effects (word-finding difficulty)", "paresthesia", "weight loss", "glaucoma symptoms (eye pain, vision changes)"],
        importantInvestigations: ["Monitor for cognitive slowing and word-finding difficulty. Encourage hydration."]
    },
    { 
        name: "TRITTICO 100mg Tab.", 
        active: "Trazodone", 
        category: "SARI (Antidepressant)",
        available: true,
        package: "20 TAB",
        halfLife: "5-9 hours",
        sideEffects: ["Sedation", "dizziness", "orthostatic hypotension", "dry mouth", "nausea", "headache"],
        interactions: ["CNS depressants", "MAOIs (contraindicated)", "CYP3A4 inhibitors (e.g., ketoconazole)"],
        monitor: ["Sedation", "orthostatic hypotension", "priapism (rare)", "dizziness"],
        importantInvestigations: ["Risk of priapism (rare but serious). Often used off-label for insomnia at lower doses."]
    },
    { 
        name: "TRITTICO 50mg Tab.", 
        active: "Trazodone", 
        category: "SARI (Antidepressant)",
        available: true,
        package: "20 TAB",
        halfLife: "5-9 hours",
        sideEffects: ["Sedation", "dizziness", "orthostatic hypotension", "dry mouth", "nausea", "headache"],
        interactions: ["CNS depressants", "MAOIs (contraindicated)", "CYP3A4 inhibitors (e.g., ketoconazole)"],
        monitor: ["Sedation", "orthostatic hypotension", "priapism (rare)", "dizziness"],
        importantInvestigations: ["Risk of priapism (rare but serious). Often used off-label for insomnia at lower doses."]
    },
    { 
        name: "STELLASIL 5mg Tab.", 
        active: "Trifluperazine", 
        category: "Typical Antipsychotic (First Generation, Phenothiazine)",
        available: true,
        package: "30 TAB",
        halfLife: "8 hours",
        sideEffects: ["Extrapyramidal symptoms", "sedation", "anticholinergic effects (dry mouth, blurred vision)", "orthostatic hypotension"],
        interactions: ["CNS depressants", "anticholinergics", "levodopa (antagonizes effect)"],
        monitor: ["EPS", "akathisia", "sedation", "tardive dyskinesia", "photosensitivity"],
        importantInvestigations: ["Higher potency typical antipsychotic. Monitor closely for EPS and akathisia."]
    },
    { 
        name: "STELLASIL 1mg Tab.", 
        active: "Trifluperazine", 
        category: "Typical Antipsychotic (First Generation, Phenothiazine)",
        available: false,
        package: "30 TAB",
        halfLife: "8 hours",
        sideEffects: ["Extrapyramidal symptoms", "sedation", "anticholinergic effects (dry mouth, blurred vision)", "orthostatic hypotension"],
        interactions: ["CNS depressants", "anticholinergics", "levodopa (antagonizes effect)"],
        monitor: ["EPS", "akathisia", "sedation", "tardive dyskinesia", "photosensitivity"],
        importantInvestigations: ["Higher potency typical antipsychotic. Monitor closely for EPS and akathisia."]
    },
    { 
        name: "DEPAKINE CHRONO 500mg Tab.", 
        active: "Valproic Acid", 
        category: "Anticonvulsant / Mood Stabilizer",
        available: true,
        package: "30 TAB",
        halfLife: "9-16 hours",
        sideEffects: ["Nausea", "sedation", "tremor", "weight gain", "hair loss", "thrombocytopenia", "hepatotoxicity"],
        interactions: ["Other CNS depressants", "lamotrigine (increases risk of SJS)", "aspirin/warfarin (increased bleeding risk)"],
        monitor: ["Tremor", "weight gain", "hair loss", "encephalopathy signs (lethargy, confusion)"],
        importantInvestigations: ["Monitor CBC, LFTs, and valproic acid levels. High risk of neural tube defects in pregnancy."]
    },
    { 
        name: "EFEXOR XR 150mg Cap.", 
        active: "Venlafaxine", 
        category: "SNRI (Antidepressant)",
        available: true,
        package: "14 CAP",
        halfLife: "5 hours",
        sideEffects: ["Nausea", "headache", "insomnia", "hypertension", "sweating", "sexual dysfunction", "dizziness"],
        interactions: ["MAOIs (contraindicated)", "serotonergic drugs", "NSAIDs/aspirin (increased bleed risk)"],
        monitor: ["Blood pressure", "mood changes", "suicidal ideation", "withdrawal symptoms", "serotonin syndrome"],
        importantInvestigations: ["Monitor blood pressure, especially at higher doses (>150mg/day). Can be difficult to discontinue."]
    },
    { 
        name: "EFEXOR XR 75mg Cap.", 
        active: "Venlafaxine", 
        category: "SNRI (Antidepressant)",
        available: true,
        package: "14 CAP",
        halfLife: "5 hours",
        sideEffects: ["Nausea", "headache", "insomnia", "hypertension", "sweating", "sexual dysfunction", "dizziness"],
        interactions: ["MAOIs (contraindicated)", "serotonergic drugs", "NSAIDs/aspirin (increased bleed risk)"],
        monitor: ["Blood pressure", "mood changes", "suicidal ideation", "withdrawal symptoms", "serotonin syndrome"],
        importantInvestigations: ["Monitor blood pressure. Withdrawal syndrome common if stopped abruptly."]
    },
    { 
        name: "VENLLAMASH 75mg Cap.", 
        active: "Venlafaxine", 
        category: "SNRI (Antidepressant)",
        available: true,
        package: "30 CAP",
        halfLife: "5 hours",
        sideEffects: ["Nausea", "headache", "insomnia", "hypertension", "sweating", "sexual dysfunction", "dizziness"],
        interactions: ["MAOIs (contraindicated)", "serotonergic drugs", "NSAIDs/aspirin (increased bleed risk)"],
        monitor: ["Blood pressure", "mood changes", "suicidal ideation", "withdrawal symptoms", "serotonin syndrome"],
        importantInvestigations: ["Monitor blood pressure, especially at higher doses. Withdrawal syndrome common."]
    },
    { 
        name: "VILAZOVER 40mg Tab.", 
        active: "Vilazodone", 
        category: "SSRI & 5-HT1A Receptor Partial Agonist",
        available: false,
        package: "30 TAB",
        halfLife: "25 hours",
        sideEffects: ["Diarrhea", "nausea", "insomnia", "vomiting", "dizziness"],
        interactions: ["MAOIs (contraindicated)", "serotonergic drugs", "NSAIDs/aspirin (increased bleed risk)"],
        monitor: ["GI symptoms (diarrhea, nausea)", "mood changes", "sexual dysfunction", "activation"],
        importantInvestigations: ["Must be taken with food to ensure adequate absorption."]
    },
    { 
        name: "VILAPHORIA 40mg Tab", 
        active: "Vilazodone", 
        category: "SSRI & 5-HT1A Receptor Partial Agonist",
        available: true,
        package: "30 TAB",
        halfLife: "25 hours",
        sideEffects: ["Diarrhea", "nausea", "insomnia", "vomiting", "dizziness"],
        interactions: ["MAOIs (contraindicated)", "serotonergic drugs", "NSAIDs/aspirin (increased bleed risk)"],
        monitor: ["GI symptoms (diarrhea, nausea)", "mood changes", "sexual dysfunction", "activation"],
        importantInvestigations: ["Must be taken with food to ensure adequate absorption."]
    },
    { 
        name: "DEPRATIOX 10mg Tab.", 
        active: "Vortioxetine", 
        category: "Multimodal Antidepressant",
        available: true,
        package: "20 TAB",
        halfLife: "66 hours",
        sideEffects: ["Nausea", "constipation", "vomiting", "sexual dysfunction", "dizziness", "flushing"],
        interactions: ["MAOIs (contraindicated)", "serotonergic drugs", "NSAIDs/aspirin (increased bleed risk)"],
        monitor: ["GI symptoms", "mood changes", "cognitive function", "sexual dysfunction"],
        importantInvestigations: ["May have a lower incidence of sexual dysfunction compared to some SSRIs/SNRIs."]
    },
    { 
        name: "BRINTELLIX 10MG Tab.", 
        active: "Vortioxetine", 
        category: "Multimodal Antidepressant",
        available: false,
        package: "14 TAB",
        halfLife: "66 hours",
        sideEffects: ["Nausea", "constipation", "vomiting", "sexual dysfunction", "dizziness", "flushing"],
        interactions: ["MAOIs (contraindicated)", "serotonergic drugs", "NSAIDs/aspirin (increased bleed risk)"],
        monitor: ["GI symptoms", "mood changes", "cognitive function", "sexual dysfunction"],
        importantInvestigations: ["May have a lower incidence of sexual dysfunction compared to some SSRIs/SNRIs."]
    },
    { 
        name: "HYPNOR 7.5mg Tab.", 
        active: "Zopiclone", 
        category: "Non-Benzodiazepine (Z-Drug)",
        available: false,
        package: "10 TAB",
        halfLife: "5 hours",
        sideEffects: ["Bitter metallic taste", "dry mouth", "drowsiness", "headache", "dizziness", "rebound insomnia"],
        interactions: ["CNS depressants (alcohol, opioids, other sedatives)"],
        monitor: ["Sedation", "confusion", "ataxia", "dependence", "withdrawal"],
        importantInvestigations: ["Risk of tolerance and dependence. Avoid alcohol. Can cause complex sleep behaviors."]
    },
    {
        name: "GAPTIN 100mg Cap.", 
        active: "Gabapentin", 
        category: "Anticonvulsant / Neuropathic pain agent (GABA analog, though not acting directly on GABA receptors)",
        available: true,
        package: "30 CAP",
        halfLife: "57 hours",
        sideEffects: ["Dizziness", "Somnolence (drowsiness)", "Fatigue", "Ataxia (loss of coordination)", "Peripheral edema", "Nystagmus", "Weight gain", "Headache"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["CNS depression (drowsiness, dizziness, impaired coordination)  especially when initiating or increasing dose", "Mood changes (depression, anxiety, suicidal ideation)  per FDA black box warning for antiepileptics", "Signs of hypersensitivity (rash, fever, lymphadenopathy)", "Peripheral edema  monitor for swelling in extremities", "Respiratory depression  especially when combined with CNS depressants (opioids, benzodiazepines)", "Weight gain and appetite changes", "Withdrawal symptoms (insomnia, nausea, headache, anxiety)  avoid abrupt discontinuation."],
        importantInvestigations: ["Renal function tests (serum creatinine, eGFR)  Gabapentin is renally excreted; dose adjustment needed in renal impairment", "Liver function tests (LFTs)  Rare hepatotoxicity; baseline and periodic monitoring in long-term use", "Electrolytes  Occasionally monitored due to edema or fluid retention."]
    },
        {
        name: "GAPTIN 300mg Cap.", 
        active: "Gabapentin", 
        category: "Anticonvulsant / Neuropathic pain agent (GABA analog, though not acting directly on GABA receptors)",
        available: true,
        package: "30 CAP",
        halfLife: "57 hours",
        sideEffects: ["Dizziness", "Somnolence (drowsiness)", "Fatigue", "Ataxia (loss of coordination)", "Peripheral edema", "Nystagmus", "Weight gain", "Headache"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["CNS depression (drowsiness, dizziness, impaired coordination)  especially when initiating or increasing dose", "Mood changes (depression, anxiety, suicidal ideation)  per FDA black box warning for antiepileptics", "Signs of hypersensitivity (rash, fever, lymphadenopathy)", "Peripheral edema  monitor for swelling in extremities", "Respiratory depression  especially when combined with CNS depressants (opioids, benzodiazepines)", "Weight gain and appetite changes", "Withdrawal symptoms (insomnia, nausea, headache, anxiety)  avoid abrupt discontinuation."],
        importantInvestigations: ["Renal function tests (serum creatinine, eGFR)  Gabapentin is renally excreted; dose adjustment needed in renal impairment", "Liver function tests (LFTs)  Rare hepatotoxicity; baseline and periodic monitoring in long-term use", "Electrolytes  Occasionally monitored due to edema or fluid retention."]
    },
    {
        name: "GAPTIN 400mg Cap.", 
        active: "Gabapentin", 
        category: "Anticonvulsant / Neuropathic pain agent (GABA analog, though not acting directly on GABA receptors)",
        available: true,
        package: "30 CAP",
        halfLife: "57 hours",
        sideEffects: ["Dizziness", "Somnolence (drowsiness)", "Fatigue", "Ataxia (loss of coordination)", "Peripheral edema", "Nystagmus", "Weight gain", "Headache"],
        interactions: ["CNS depressants", "CYP3A4 inhibitors/inducers (e.g., ketoconazole, carbamazepine)", "antihypertensives"],
        monitor: ["CNS depression (drowsiness, dizziness, impaired coordination)  especially when initiating or increasing dose", "Mood changes (depression, anxiety, suicidal ideation)  per FDA black box warning for antiepileptics", "Signs of hypersensitivity (rash, fever, lymphadenopathy)", "Peripheral edema  monitor for swelling in extremities", "Respiratory depression  especially when combined with CNS depressants (opioids, benzodiazepines)", "Weight gain and appetite changes", "Withdrawal symptoms (insomnia, nausea, headache, anxiety)  avoid abrupt discontinuation."],
        importantInvestigations: ["Renal function tests (serum creatinine, eGFR)  Gabapentin is renally excreted; dose adjustment needed in renal impairment", "Liver function tests (LFTs)  Rare hepatotoxicity; baseline and periodic monitoring in long-term use", "Electrolytes  Occasionally monitored due to edema or fluid retention."]
    },
    { 
        name: "CLOPIXOL DEPOT 200mg/ml Amp.", 
        active: "Zuclopenthixol Decanoate", 
        category: "Typical Antipsychotic (Depot)",
        available: true,
        package: "10 AMP",
        halfLife: "3-4 weeks",
        sideEffects: ["Extrapyramidal symptoms", "sedation", "weight gain", "hyperprolactinemia", "anticholinergic effects"],
        interactions: ["CNS depressants", "levodopa (antagonizes effect)", "guanethidine"],
        monitor: ["EPS", "sedation", "akathisia", "injection site reactions", "clinical stability"],
        importantInvestigations: ["Deep IM injection. Long-acting formulation. Monitor for EPS and akathisia."]
    },
    { 
        name: "CLOPIXOL ACUPHASE 100MG/ml Amp.", 
        active: "Zuclopenthixol Decanoate", 
        category: "Typical Antipsychotic (Depot)",
        available: false,
        package: "10 AMP",
        halfLife: "3-4 weeks",
        sideEffects: ["Extrapyramidal symptoms", "sedation", "dizziness", "orthostatic hypotension"],
        interactions: ["CNS depressants", "levodopa (antagonizes effect)", "guanethidine"],
        monitor: ["EPS", "sedation", "akathisia", "injection site reactions", "clinical stability"],
        importantInvestigations: ["Used for rapid tranquilization in acute agitation. Short-acting depot formulation."]
    }
];

let medications = []; // Will store loaded medications

// Function to load medication data
function loadMedicationData() {
    medications = medicationData;
    
    // Update placeholder after loading
    document.getElementById('search-input').placeholder = "medication name or active ingredient";
    
    // Show initial state
    const resultsList = document.getElementById('results-list');
    resultsList.innerHTML = `
        <div class="no-results fade-in">
            <i class="fas fa-info-circle"></i>
            <p>Type at least 2 characters to search</p>
            <p style="font-size:0.9rem; margin-top:10px;">Try: olanzapine, lithium</p>
        </div>
    `;
}

// Function to show medication details
function showMedicationDetails(medName) {
    const medication = medications.find(med => med.name === medName);
    if (!medication) return;
    
    // Hide search section and search results, show detail page
    document.querySelector('.search-section').classList.add('hidden');
    document.querySelector('.results-container').classList.add('hidden');
    document.getElementById('medication-detail').classList.remove('hidden');
    
    // Populate detail page
    document.getElementById('detail-med-name').textContent = medication.name;
    document.getElementById('detail-active').textContent = medication.active;
    document.getElementById('detail-category').textContent = medication.category;
    document.getElementById('detail-package').textContent = medication.package;
    document.getElementById('detail-half-life').textContent = medication.halfLife;
    
    const availabilityEl = document.getElementById('detail-availability');
    availabilityEl.textContent = medication.available ? 'Available' : 'Not Available';
    availabilityEl.className = medication.available ? 'available-badge' : 'not-available-badge';
    
    // Populate side effects
    const sideEffectsList = document.getElementById('detail-side-effects');
    sideEffectsList.innerHTML = '';
    medication.sideEffects.forEach(effect => {
        const li = document.createElement('li');
        li.textContent = effect;
        sideEffectsList.appendChild(li);
    });
    
    // Populate interactions
    const interactionsList = document.getElementById('detail-interactions');
    interactionsList.innerHTML = '';
    medication.interactions.forEach(interaction => {
        const li = document.createElement('li');
        li.textContent = interaction;
        interactionsList.appendChild(li);
    });
    
    // Populate monitor
    const monitorList = document.getElementById('detail-monitor');
    monitorList.innerHTML = '';
    medication.monitor.forEach(item => {
        const li = document.createElement('li');
        li.textContent = item;
        monitorList.appendChild(li);
    });
    
    // Populate important investigations
    const investigationsList = document.getElementById('detail-investigations');
    investigationsList.innerHTML = '';
    medication.importantInvestigations.forEach(item => {
        const li = document.createElement('li');
        li.textContent = item;
        investigationsList.appendChild(li);
    });
}

// Function to go back to search results
function goBackToSearch() {
    document.getElementById('medication-detail').classList.add('hidden');
    document.querySelector('.search-section').classList.remove('hidden');
    document.querySelector('.results-container').classList.remove('hidden');
}